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The work presented in this dissertation was supported by Karolinska Institutet, the
Whitaker Foundation International Program Summer Grant, and the FedEx Institute of
Technology Development Grant. Research reported in this dissertation was supported by the
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of
Health under Award Number F31AR072502. The content is solely the responsibility of the
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ABSTRACT
Spatiotemporal organization and regulation of genomic and epigenomic processes
is a phenomenon central to life. The pursuit of knowledge about these processes often requires
specialized tools to be able to dissect biological mechanisms. CRISPR/Cas has emerged as a
powerful tool for genome engineering, and has seen widespread use. Coupling CRISPR/Cas
systems with tools that allow for spatiotemporal control is predicted to be transformational to the
ability to perturb systems and gain the insights necessary to understand a diverse set of biological
questions, and ultimately treat some of the most pervasive and elusive diseases. This dissertation
describes the development of an optogenetic system to harness the full potential of CRISPR/Cas
systems. To this end, we present BluVIPR, a system to control guide RNA production for precise
spatiotemporal control of orthogonal CRISPR/Cas systems. We make special emphasis on the
versatility of the system, and the compatibility with current mouse models that are stalwarts of
biomedical research. We then show a proof of concept study for the delivery of light gradients to
cells engineered with the BluVIPR system via air gap electrospun templates, envisioning how
biomaterial-guided optogenetics could be used as a therapeutic strategy for interfacial tissue
engineering. We finally show how the versatility and orthogonality of BluVIPR would allow for
the development of a synthetic gene regulatory network, composed of a simple, geneticallyencoded, digital demultiplexer circuit, to interpret light gradients as a cue for opposing gradient
production of growth factors. We believe that this optogenetic CRISPR/Cas system is an
important contribution to the toolkit of diverse biological fields of research, and envision many
exciting applications in tissue engineering, tumor immunology, developmental biology, and
beyond.
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CHAPTER 1
INTRODUCTION

Investigation of continuously fluctuating biological processes, and the subsequent desire
to develop therapeutic avenues from these findings, frequently necessitates the use of tools that
allow precise regulation of genomic and epigenomic features in a spatiotemporal fashion. The
ability to control the cellular transcriptome, genome, and epigenome allows the researcher to
create models to interrogate function and relationships, and ultimately identify key elements. The
ability to control these cellular features in a manner that is defined by predetermined time and
space constraints allows for the model to resemble more closely the intricate and fluid states of
biological systems. Despite the importance of tools that could dissect the “where” and “when” of
biological phenomena, flexible, reversible, and multifunctional tools are not currently abundant.
Optogenetics has been one such tool that has seen widespread use in neuroscience, enabling the
precise spatiotemporal control of neurons, especially through the use of Channelrhodopsin-2
light-sensitive ion channels1. Light is especially well-suited for spatiotemporal regulation of
events, as it is easily focused on a desired location, and can be switched on and off in a precise
temporal pattern. The success of neuronal control through light has motivated the translation of
similar tools to other fields of biology, where the regulation of transcription, both for transgenes
and endogenous genes, has been a main target1–4.
The introduction of transgenes, and the precise modification of transcriptome, genome,
and epigenome in cells and organisms has been a major endeavor in itself. Recent advances have
made genome engineering more accessible to laboratories worldwide, accelerating research and
enabling rapid generation of complex models. The genome engineering field experienced a
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paradigm shift when Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
systems were adapted for RNA-guided editing of eukaryotic genomes. The CRISPR toolkit has
been expanded by discovery of divergent CRISPR systems, mutation of the CRISPR associated
proteins (Cas) and by addition of effectors that endow the system with diverse functions,
including transcriptional activation and repression, base editing, genomic labeling, among
others5. In the pursuit of spatiotemporal regulation of cellular functions, CRISPR-based
optogenetic tools have been developed to enable control of CRISPR/Cas systems with light.
These CRISPR optogenetic tools are predominantly constructed with dimerizing elements that
fuse split Cas, or fuse effectors to Cas in response to light3,6–9. This Cas-centered approach limits
the flexibility of current optogenetic CRISPR tools, as they require protein engineering, are
mostly limited to transcriptional activation/repression, and are not compatible with existing
CRISPR resources (such as commercially available CRISPR mice).
The overarching goal of this project was to develop an optogenetic CRISPR tool that is
flexible (allowing use of all available CRISPR functionalities), orthogonal (allowing use of
different CRISPR systems, separately or concomitantly), and compatible with existing CRISPR
resources. Additionally, an example of how this tool could be utilized for precise control of
growth factor production in tissue engineering applications was explored.
This chapter presents a succinct overview of the importance of spatiotemporal control of
cellular processes, strategies to regulate these processes, CRISPR/Cas tools, optogenetic tools,
and enthesis tissue engineering approaches. Ultimately, all the aforementioned aspects will
provide the backdrop to the work presented in this dissertation.
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TIME AND SPACE IN BIOLOGICAL SYSTEMS
Living systems have the inherent ability to maintain stable conditions in unstable
environments, requiring adaptive mechanisms in constant flux and interconnection10. This
tendency towards stability has been termed homeostasis or homeorhesis, with the former
describing a system in steady-state, whereas the latter describes a system that returns to a
dynamic tendency or path11. The coordinated effort that is required to maintain equilibrium in a
multilevel organic system is complex, varying through space and time, and has been
mathematically modeled by multiple researchers12,13. Cells adapt to their environment and
maintain stable conditions through processes that are centered in the expression of genes
(proteins), and this is in turn regulated by complex automatic control systems involving
epigenetic, genetic, and posttranslational machineries14. Cybernetics, a term used to describe the
communication and automatic control systems in living things and machines, was first coined by
Wiener15. Cybernetic features have been described and modeled to understand underpinning
biological mechanisms, ranging from communal to molecular scales in multilevel living
systems16–19. With these models, researchers have attempted to dissect a multitude of
mechanisms, such as metabolic homeorhesis of S. cerevisiae and Tumor Necrosis Factor
orchestration of cellular functions in diverse modes of action18,19. A directing constant in these
models is that organization and interpretation of signals by living systems require precise
spatiotemporal control of cues and responses to these cues. In the following paragraphs, a few
examples of this spatiotemporal regulation will be presented, focusing on embryonic
development and biological clocks.
It is not surprising that the term homeorhesis was coined by Waddington in the
context of cellular differentiation and morphogenesis in embryonic development14. The adhesion
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to developmental paths (chreods), despite changes in the environment, is a hallmark of
embryonic development that gives rise to complex multicellular organisms and specialized
tissues from an unicellular origin11. Germ layers arising from asymmetric cell divisions
establishing somatic and germline founder cells in the C. elegans embryo show distinctive
spatiotemporal gene expression profiles, and these have been used by Hashimshony et al. to
elucidate the evolutionary appearance of the germ layers20. It is also through spatiotemporal
differential gene expression that left-right asymmetry originates in the developing embryo, as
evidenced by the role of Rho signaling on the opposing sides of the primitive gut tube, described
by Morckel et al.21. Furthermore, Meyer et al. described branching of epithelial tubes as a
consequence of spatiotemporal control by morphogenetic molecules in the developing kidney22.
It should be apparent that spatiotemporal regulation is a major contributor to embryonic
development, and can be implicated in many more developmental phenomena than the selected
examples above. It is also interesting to ponder on how the spatiotemporal regulatory cues
presented to the embryo are themselves regulated in a spatiotemporal fashion, involving multiple
overlaid cybernetic feedback loops. The sequence of early reproductive events from
folliculogenesis to blastocyst implantation require coordinated and spatiotemporally regulated
endocrine, paracrine, and autocrine communication23. The interpretation of signaling cues and
subsequent responses in the early and developing embryo involve direct gene expression
regulation through signaling cascades, chromatin interaction networks that regulate epigenetic
and genetic states, spatiotemporal network structures, and liquid-like condensates directing
transgenerational epigenetic inheritance24–26. Spatiotemporal gene regulation is also part of the
directional sensing mechanisms that allow cells to exhibit chemotaxis and respond to molecular
gradients to transport themselves to determined locations, enabling spatial organization of
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embryonic tissues and response to injury27. These molecular mechanisms implicated in
embryonic development are retained through post-natal timeframes in specialized responses,
particularly healing responses. Fracture healing is an example, where mechanisms that regulate
cell migration, differentiation, and growth are recapitulated in a spatiotemporally regulated
manner to repair skeletal structures in a post-natal environment28.
The duration of embryonic development is determined by internal biological clocks that
are species-specific, and are part of one of two major classes of biological clock: hourglasses29.
The second major class of biological clock are oscillators, and these include the well-known
circadian clocks, that in mammals are a network of interconnected clocks with a central
pacemaker in the suprachiasmatic nucleus (SCN) of the ventral hypothalamus, which is adjusted
by light cues sensed by the retina29. The tissue structure of the SCN exhibits a particular spatial
organization of SCN cellular oscillators, coupled in a way that allows for gene expression to set
an intermediate period, integrating the signals of the individual oscillators30. This integrated
signal is then propagated to the rest of the network, setting interdependent nodes that, in turn,
regulate local events in a spatiotemporal manner30,31. This system of multiple autonomous, but
interconnected, clocks improves adaptation to variable environments32. Though light is the major
zeitgeber for adjusting central circadian clocks, other time keeping signals, like feeding, are
important for peripheral clocks, and these set gene expression patterns that are tissue-specific
(and thus spatiotemporally constrained in nature)32,33. The cybernetic networks of these multiple
clocks, responding to multiple cues and being recalibrated in a spatiotemporal manner, sets a
spatiotemporal regulator for virtually every cell in an organism29. Thus, from pre-implantation
events to death, living systems are responding to their environment through a series of
interconnected networks that maintain homeostasis and homeorhesis through spatiotemporal

5

regulation of molecular mechanisms central to life itself, and anchored in the central dogma of
molecular biology.
Given the importance of the cybernetic nature of living things, and how spatiotemporal
patterning of gene expression lies at the heart of these control systems, it follows that tools that
allow for better modelling and precise perturbation of the genetic and epigenetic aspects of the
systems, to dissect component function and causal relationships, are highly desirable. Balling
expresses this desire very well: “Imagine titrating the expression of single genes in specific cell
populations at will”34. Armed with the information about networks and biological dynamics that
these tools will facilitate, the ability to understand and eventually modulate complex biological
systems for therapeutic aims will grow significantly34.
TOOLS FOR SPATIOTEMPORAL GENOMIC AND EPIGENOMIC REGULATION
In the pursuit of spatiotemporal regulation of genomic and epigenomic structures and
processes, researchers have developed an ever-growing arsenal of tools and techniques. The
following sections will provide a succinct overview of common approaches to inducible genomic
and epigenomic engineering, giving context to, and providing the foundations of, the work
presented in this dissertation.
TEMPORAL REGULATION
Inducibility of gene expression at a determined time point allows researchers to study
genes that are toxic when expressed constitutively or in particular stages of development, and
can give rise to the opportunity to observe the effect of gene expression by presenting clear
“before” and “after” scenarios35. Conversely, inducible gene repression expands the toolset by
presenting loss of expression in a precisely time-determined manner. To date, most inducible
expression or repression systems rely on small molecules as effectors35–40. The first widely
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available inducible gene expression system to be developed was the Tet-Off system41. In this
system the tTA transactivator is created by fusing the E. coli tet repressor (TetR) with the
herpesvirus transactivation domain VP1636,41. The presence of tet operator DNA sequences
upstream of a target gene and a minimal promoter allows the binding of tTA and subsequent
transcription of the downstream sequences41. Tetracycline binds tTA, blocking DNA binding
domains and abolishing transcription41. A mutated form of tTA, termed reverse tTA (rtTA),
binds DNA only in the presence of tetracycline or its analogues, effectively reversing the stimuli
responsiveness of the inducible expression system, creating a Tet-On switch36. These systems,
Tet-On and Tet-Off, allow precise regulation of gene expression upon addition of tetracycline or
its analogues (i.e. doxycycline), present relatively low basal levels of expression (leakiness), and
potent activation (dynamic range)35,36. Due to the convenience and cost effectiveness of
doxycycline administration, and good bioavailability when used in vivo, Tet-On systems in
particular have seen widespread use in diverse fields of biology36. Alternative approaches using
the same allosteric strategy utilize steroids, like ecdysone (from Drosophila) or a mutant human
progesterone receptor that only binds progesterone antagonist RU48635,36,42. In both of these
systems, DNA binding domains are fused to VP16, activating the gene downstream of the
recognition elements and minimal promoter in a drug-inducible manner36,42. Similarly, PipOFF
and PipON systems rely on fusion transactivators derived from the repressor pristinamycininduced protein (Pip) to regulate gene expression under stimulus of streptogramin antibiotics37.
These drug-inducible gene expression tools have been very useful for the precise regulation of
transgene expression in a temporal basis, but researchers have also developed tools based on
drug-inducible promoters to target (and silence) endogenous genes. For example, Kappel et al.
described a system in which an H1 promoter expresses short hairpin RNA (shRNA) under the
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control of tetracycline39. Similarly, Gupta et al. developed a U6 inducible promoter that
expresses shRNA under the control of ecdysone38.
An interesting addition to the toolkit aimed at temporal regulation of gene expression is
the utilization of heat shock protein promoters to activate transcription when cells are exposed to
elevated temperatures (42°C)43,44. These systems utilize native cellular responses, mainly heat
shock protein 70 upregulation, that regulate gene expression patterns to protect the cell from
elevated temperatures43. Yang et al. have described a system that uses a heat shock promoter to
drive microRNA mimics, targeting and silencing endogenous targets45. The potential off target
effects of activating the heat shock pathway in an experimental or therapeutic setup are concerns
when using this system. Of note, this system can be combined with focused ultrasound to
generate precise spatial regulation of gene expression, in addition to the temporal regulation
aspect already discussed43.
SPATIAL REGULATION
The phenotype of a multicellular organism arises when differential gene expression is
orchestrated in a precise spatiotemporal manner46. The mechanisms that regulate this cell
lineage-specific differential expression are therefore extremely important research targets, but
they are themselves a tool to limit expression of a gene of interest to specific cells or tissues,
bringing spatial control to transgene expression46–48. In its simplest form “transcriptional
targeting” through tissue-specific differential expression places a transgene downstream of the
tissue-specific promoter of choice49. Efforts to map these tissue-specific regulatory elements
have yielded a number of identified genes whose promoter is differentially activated in a cell or
tissue-type discriminating manner50. Thus, once a researcher has identified the adequate tissuespecific promoter, the gene of interest is cloned downstream of a copy of the regulatory element
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for this promoter and the differential expression innate to the biological system ensures that the
gene of interest is expressed in the desired tissue. Examples of this approach have targeted
hematopoietic cell lineages through CD43, neurons through platelet-derived growth factor Bchain (PDGF-b), and endothelial cells through TIE2, among others51–53. The major limiting
factor when using simple transcriptional targeting as described above, is that robust transcription
is seldom achieved, limiting the dynamic range of expression for the gene of interest47,52,54. Low
transcription levels have been tackled in multiple ways, mainly by adding enhancers or
transactivators to the native tissue-specific regulatory elements and transcription factor; or by
utilizing site-specific recombination strategies (like the Cre-Lox system). Liu et al. placed
cytomegalovirus (CMV) enhancers upstream of PDGF-b promoter sequences to improve
transcriptional levels of transgene expression in neurons52. Other groups have attempted to boost
transcription through the coupling of transactivation domains (VP16, p65, etc) to either the
native tissue-specific transcription factor protein, or to xenogeneic transactivator fusions (Gal4,
tTA, etc) that are regulated by the endogenous tissue-specific promoter and then bind regulatory
elements of the transgene, driving robust transcription53,55–57. It is important to note that these
strategies using inducible transactivator fusions also confer temporal regulation of the transgene,
as seen in the previous section. In a parallel approach, the Cre-Lox site-specific recombination
system can be used to remove a Lox-flanked stop cassette in the transgene, effectively activating
transcription and translation of the gene of interest58. To limit the activity of the Cre recombinase
to specific tissues, the sequence encoding the recombinase is placed under tissue-specific
promoter regulation48,54. In this strategy, the promotor driving the transgene can be constitutively
active or inducible, hence allowing for the possibility of temporal control of transcripts that are
only successfully translated in a spatially-restricted fashion59. Furthermore, all of the strategies
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for transcriptional targeting described thus far can be assembled in complex arrays with specific
enhancers and large genomic regions, then delivered in bacterial artificial chromosomes (BAC)
to further expand the toolset47.
Spatial regulation of gene expression through means that are not dependent on tissuespecific transcriptional targeting have also been explored, using physicochemical cues to initiate
transcription. Madio et al. described the use of magnetic resonance imaging (MRI) guided
focused ultrasound to precisely elevate temperature at a desired location and activate gene
expression through heat shock response43. Ausländer et al. developed synthetic gene regulatory
networks to control gene expression in response to pH and CO2 levels in mammalian cells60.
While other groups have recognized the inherent advantages of using light as a spatiotemporal
regulator, and these strategies will be further discussed in a latter section of this introduction.
It should be clear that a fundamental concept of spatiotemporal regulation of gene
expression is that of targeting a particular regulatory element with a transcription factor (or
transactivator fusion that binds the regulatory element). This bipartite system then allows for the
organization of one or both of the required elements in a fashion that is spatiotemporally
restricted. An exciting tool that has revolutionized genome engineering in the last decade,
CRISPR/Cas, is a bipartite system that can be targeted to specific genomic locations, thus
making it an ideal candidate for development of spatiotemporal regulatory systems of gene
expression.
CRISPR/CAS
CRISPR arrays were first noted as anomalies in prokaryotic genomes and subsequently
identified as primitive bacterial and archaeal acquired immune systems61. In its essence,
CRISPR/Cas is an RNA-guided restriction machinery, aimed at identifying and destroying
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previously encountered mobile genetic elements, such as plasmids, transposons, and
bacteriophages61,62. The sequences that lie in between the regularly interspaced palindromic
repeats are known as spacers, and are foreign genomic sequences that have been integrated into
the bacterial genome62. These sequences are transcribed into RNA and used as a guide to direct
Cas proteins to degrade invading foreign nucleic acids61,62. The ribonucleoprotein complex of
Cas and CRISPR RNA scans nucleic acid sequences and checks for complementarity to the
spacer when a protospacer adjacent motif (PAM) is recognized61. If this complementarity exists,
nuclease domains in the Cas protein cleave the foreign nucleic acid61,62. This two component
system has been engineered to function in eukaryotic organisms, targeting genomic sequences by
easily manufactured RNA sequences, greatly improving the ease of genome engineering62. The
diversity of CRISPR/Cas systems and the efforts to classify these will be discussed in a
following paragraph of this introduction.
The first adaptations of CRISPR/Cas for eukaryotic genome engineering centered around
S. pyogenes Cas9 systems (SP Cas9)61,62. In the native SP Cas9 system, the RNA directing DNA
cleavage is transcribed in two separate parts: CRISPR RNA (crRNA) and trans-activating
CRISPR RNA (tracrRNA)61. The crRNA:tracrRNA duplex is combined into a single synthetic
chimeric transcript in engineered versions of the SP Cas9 system, and termed guide RNA
(gRNA)61. These gRNAs are designed to include an 80bp scaffold that interacts with Cas9
(specific to SP Cas9) and a 20bp targeting portion, that should be complimentary to the intended
target61,62. The target should be flanked on its 3’ end by a PAM specific to SP Cas9, NGG61,62.
When coupled to this gRNA, SP Cas9 is activated, and the PAM recognition domain is available
to recognize the three nucleotide sequence flanking the target. Once this PAM is recognized,
RuvC and HNH domains are activated, generating double stranded breaks (DSB) at the target
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site61. These DSBs are repaired by cellular DNA repair mechanisms, predominantly by the errorprone nonhomologous end joining (NHEJ) mechanism, allowing for the introduction of small
mutations (insertions or deletions (indels)) at the target site61,62. Typically, one nucleotide
insertions are predominant, followed by one nucleotide deletions as the most common indels.
These indels cause frame shift mutations, effectively abolishing the correct translation of the
target gene, generating a knock out61. If a template DNA that includes flanking sequences
homologous to the sequences adjoining the target DSB, the cell will also repair DNA through a
process known as homology-directed repair (HDR). The template DNA then serves as both a
guide for the repair mechanism, and a vehicle for introducing a new sequence into the genome,
generating knock-ins61. This nuclease activity of SP Cas9 has seen widespread use, and is the
source of the popular nickname for CRISPR/Cas systems: “gene scissors”.
Engineered point mutations in the RuvC or HNH domains of Cas9 abolish nuclease
activity, enabling the generation of a nickase Cas9 (nCas9),generating single strand breaks, if
only one domain is mutated, or a nuclease deficient Cas9 (dCas9) if both domains are mutated61.
These mutated versions of Cas9 can be fused to different effectors, conferring various
functionalities to the Cas9 system61,63–67. Targeting sequences downstream of promoters with
dCas9 represses transcription, presumably by steric hindrance, but when fused to an effector that
functions as an epigenetic transcription repressor (like Krüppel-associated box domain (KRAB)),
TRIM28 and associated chromatin remodeling machinery are recruited, strongly silencing the
target gene64,65. This strategy of CRISPR/Cas-guided gene repression is known as CRISPRi.
Conversely, if one targets a region upstream of a promoter and uses a dCas9 fused to
transactivation domains (like VP64, p65, Rta, HSF1, etc), transcription machinery is recruited
and the target gene is expressed61,63,65. This mechanism is known as CRISPRa. These
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transactivation domains can be combined to form synergistic CRISPRa synthetic transcription
factors, like dCas9-VPR (VP64, p65, and Rta), and achieve robust activation of target gene
transcription68. If an nCas9 is fused to a deaminase enzyme, precise single point mutations can
be introduced or reversed in the targeted genomic sequence66. These base editors are classified
into two main classes: Adenine base editors (ABE) and Cytosine base editors (CBE), depending
on the target nucleotide to be edited66,67. ABEs convert an A:T base pair into a G:C base pair,
while CBEs convert a C:G base pair into a T:A base pair66. CBEs include a cytidine deaminase
that removes an amine from the target cytosine, generating uracil, which is read as a T by the
DNA polymerase involved in the repair of the single stranded nick created by nCas966. The
intermediate U:G base pair generated by C deamination is quickly repaired by cellular
mechanisms, primarily employing uracil N-glycosylase (UNG) and reversing the editing event
before complete repair of the nick is completed, lowering editing efficiency dramatically66. To
overcome this, CBEs can incorporate an uracil DNA glycosylase inhibitor (UGI), which is a
DNA mimic that strongly inhibits UNG activity and allows the completion of C to T editing66.
ABEs function in an analogous manner, but employ a deoxyadenosine deaminase that was
evolved from a tRNA adenosine deaminase enzyme from E. coli66. Thus, adenine is converted
into inosine, read as G by polymerases. Cells have much less ability to remove inosine from
DNA, compared to uracil, so the use of UGIs is not necessary with ABEs66.
The CRISPR-based genome and epigenome engineering tools that have been described
this far are all centered around SP Cas9. The CRISPR/Cas system is present in many bacteria
and archaea, and considerable efforts have been set forth to identify and classify the numerous
types of systems69. This task is non trivial, mainly because the CRISPR arrays vary and don’t
contain enough information for accurate identification and classification, and because Cas
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proteins and the associated modules are frequently shuffled and varied69. CRISPR/Cas systems
are divided into two classes (1 and 2), each divided into types (I ,II ,etc) and subtypes(A, B, C,
etc)69–71. Most types that have been adapted for genome engineering applications belong to class
2 systems, mainly because the hallmark of this class is the presence of a single Cas that is
sufficient for DNA or RNA targeting and cleavage69. Each type of CRISPR system has its own
functional idiosyncrasy, with differing gRNA, PAM, and gRNA processing mechanisms (even
varying within species of the same type and subtype)69–71. This review will describe two other
class 2 CRISPR systems that are used in genome, epigenome, and transcriptome engineering.
Cas12a, previously known as Cpf1, is a type V, subtype A CRISPR/Cas system that targets DNA
and has the ability to process gRNA without any auxiliary factors69,72. Cas12a systems recognize
the TTTV PAM sequence, making it useful when targeting areas that are not GC rich and
unavailable to Cas972. The gRNA structure for Cas12a systems consist of a 5’ spacer and a 3’
direct repeat (DR) that forms a hairpin structure and couples with the Cas protein72. The four
main functions (nuclease, activation, repression, and base editing) have all been developed for
the Cas12a systems73. Altogether, the characteristics of Cas12a systems make them
complementary to Cas9 systems, expanding the available target sites in the genome, and offering
the capability of deploying orthogonal systems simultaneously. Cas13d is a type VI, subtype D
CRISPR/Cas system that targets RNA and can process gRNA without any auxiliary factors69,74.
The ability to target RNA makes this CRISPR type unique, and allows for targeting mRNA for
gene silencing, targeting mRNA splice junctions with dCas13d to induce alternative splicing, and
when fused to deaminases, targeting mRNA for base editing66,74.
As mentioned previously, CRISPR/Cas systems evolved as adaptive immune
mechanisms in prokaryotes against invading mobile genetic elements. Biological processes not
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being static, the evolutionary warfare response from these invaders led to the rise of small
proteins that hinder the activity of CRISPR/Cas: anti-CRISPR proteins (Acr). There is a
tremendous variety of Acr, with more than 20 different families described to date6. These Acr
have evolved to be highly specific and have great affinity for their targets6. The small size and
effectiveness of Acr have made them an attractive target for adding functionalities and limiting
Cas9 activities in a spatiotemporal manner6. More details of Acr and uses in spatiotemporal
regulation of CRISPR/Cas systems will be presented in chapter 5.
CRISPR/Cas systems have revolutionized the genome engineering field and their
bipartite nature (when using class 2 systems) lends itself to the possibility of combining
expression systems previously discussed for spatiotemporal regulation. Perhaps the most exciting
stimulus for generating precise spatiotemporal regulation is light. CRISPR/Cas systems have
been combined with optogenetic tools successfully. A brief overview of optogenetic tools and
the current optogenetic CRISPR/Cas toolkit will be presented in the following section.
OPTOGENETICS
Light is relatively inexpensive, highly controllable in both space and time, has minimal
untargeted effects on cells, can be dose adjustable by varying intensity, and, depending on
wavelength, can have different tissue penetration properties, and activate different lightresponsive components. It is due to these characteristics that light has long been a tool for
targeting cellular and molecular mechanisms when high spatiotemporal control is required75.
First attempts to stimulate neurons directly with lasers date back to the 1970s, with various
strategies involving fluorescent proteins, genes in combinations with chemicals, and photocaged
ligands, among others, used with varying degrees of success75. The advent of single-component
optogenetic tools, notably microbial opsins, permitted the fast development of optogenetics
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during the past 15 years, allowing for delivery of genetically-encoded optogenetic tools for
complex experiments75,76. The first microbial opsin to be adapted to optogenetic stimulation of
neurons was a channelrhodopsin, used in hippocampal neurons by Boyden et al.75,77. These
single component, genetically-encoded optogenetic tools enable highly precise spatiotemporal
regulation, and require no other external chemicals or stimuli other than light75. In comparison
with optogenetic tools that depend on photocaged or photolabile chemicals, genetically-encoded
optogenetic tools are often more economical, do not diffuse, are reversible (on/off switching),
and are easier to deliver to certain cell populations78. These advantages have propelled opsinbased optogenetic tools to widespread use, particularly in the fields related to neuroscience75,78.
Applications range from studies on basic neuronal networks to disease-oriented investigation, for
example in epilepsy, depression, spinal cord injuries, etc79–83. These tools have been employed in
in vitro and in vivo studies, allowing for precise interrogation of neuronal function even in freelymoving mammals75,82,84. While the fields related to neuroscience have benefited from the advent
of these optogenetic tools, fields that deal with excitable, depolarizing tissue have also adapted
tools for their particular needs, as evidenced by experiences in cardiac optogenetics85.
As was discussed in previous sections of this introduction, spatiotemporal patterning
plays a crucial role in embryonic development. Thus, developmental biologists have adapted and
used optogenetic tools86. For non-neuronal optogenetics, microbial opsins and related tools have
limited functionality, therefore it was the adaptation of cryptochrome, phytochrome, and lightsensitive proteins for optogenetic perturbations that carved a path to utilities within other fields86.
Light-sensitive proteins that do not require addition of foreign chromophores are particularly
important tools, as they are then single component, genetically-encoded optogenetic tools86.
Light-Oxygen-Voltage (LOV) sensing domains are particularly interesting, as they undergo
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reversible, light-mediated conformational changes that enable protein-protein and protein-DNA
interactions86,87. The allosteric function granted by the interactions with protein domains or
nucleic acids has allowed this toolset to create nuclear import, signaling cascade, and
transcription regulation optogenetic tools86,88–90.
EL222 is a protein from E. litoralis in which an LOV domain binds and inhibits a helixturn-helix (HTH) DNA binding domain in dark state, and releases the HTH under blue light
(470nm wavelength), allowing it to bind DNA (Figure 1)89. The chromophore for EL222 is
flavin which is present in eukaryotic cells, enabling use of EL222 in mammalian cells, including
human89,90. The recognition elements, DNA sequences in the bacterial genome, that EL222 HTH
binds to have been identified, and analogous sequences have been placed upstream of a minimal
TATA box promoter to enable the use of an VP16-EL222 fusion to act as a synthetic
transcription factor and drive expression of a transgene90. This strategy is depicted in chapter 3,
Figure 3. EL222 has been successfully used in mammalian cells, in vivo in zebrafish, and even
to drive Cas9 expression to enable optogenetic control of CRISPR/Cas nuclease function90,91. As
the VP16-EL222 system was one of the foundations for the work presented in this thesis, more
details about this tool will be discussed in chapter 3.

Figure 1: Schematic representation of EL222 monomers in dark state, and their dimerization under light stimulation. The
dimerization exposes the HTH domain, allowing the dimer to bind DNA. C120 is the engineered, repeated recognition element.
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LOVs and other light-activated dimerization strategies have been employed in the pursuit
of optogenetic CRISPR/Cas tools, beyond the previously discussed example with EL222. A
common trait is that most reported strategies to date have focused on the Cas protein portion of
the CRISPR/Cas system. Approaches in which the Cas protein is split and each half is fused to
photo-activatable dimerizing domains have been successfully used by several groups6. Other
tools have fused dimerizing domains, particularly cryptochrome domains, to a dCas9 and an
effector (e.g. transactivation domains, like VP64), like the LACE system by Polstein et al.3. The
use of light-induced dimerization domains that would sterically hinder the DNA binding cleft of
Cas have also been explored6,7. While successful, these Cas-centered approaches require protein
engineering of the Cas itself, limiting orthogonality and the use of off the shelf transgenic animal
models. The few attempts at regulating gRNA-centered optogenetic control of CRISPR/Cas have
revolved around caged or otherwise chemically modified gRNAs that gain function upon light
exposure6,8,9. These systems are limited by the need of introducing chemically modified gRNAs,
a non-trivial task in in vivo models. This dissertation describes the development of a gRNAcentered optogenetic CRISPR/Cas tool, using EL222, in chapter 3.
As the use of non-neuronal optogenetic tools have increased in basic research, the crossover of these tools to synthetic biology and possible therapeutic avenues has begun. One
example is the work by Ausländer et al., where optogenetic gene regulatory networks (GRN) in
cellular implants for diabetes treatment have been explored92. As a showcase of the potential
uses of a CRISPR/Cas optogenetic tool that could integrate orthogonality, biomaterial-mediated
optogenetic synthetic biology, anti-CRISPR proteins, and precise spatiotemporal regulation for
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morphogenetic gradient formation, this dissertation describes tissue engineering of the enthesis
as an example application in chapters 4 and 5.
EXAMPLE APPLICATION
In the USA alone, more than half of the 100,000 people that undergo anterior cruciate
ligament reconstruction surgery and nearly 80 percent of the 500,000 that have rotator cuff
repairs every year will experience repair failure, mostly due to the current inability to regenerate
a properly functioning enthesis93–96. High failure rates lead to significantly increased cost and
time to recovery93. The specialized interface referred to as the enthesis, the insertion of
tendons/ligaments into bone, is a highly-organized tissue presenting continuous gradients of
structural and mechanical properties that allow smooth force transfer, protecting and maintaining
the tendon/ligament insertion (Figure 2). The lack of regeneration of the enthesis leads to high
failure rates after these procedures due to formation of a discrete transition of tissue
characteristics which acts as a force concentrator that, under mechanical loading, is the site of
rupture93,96. The clinical importance of regenerating the natural structure of entheses have made
them a recent focus of tissue engineering, with the generation of smooth mechanical and
structural gradients still a major challenge. The enthesis is divided into four zones with
extracellular matrices (ECM) and cell types varying in a smooth gradient fashion 93. The first
zone of the enthesis is the tendon/ligament proper, characterized by parallel collagen type I
fibers, arrays of elongated fibroblasts, and proteoglycans94. This zone has mechanical properties
similar to those of the tendon/ligament95. The second zone is uncalcified fibrocartilage with
round fibrochondrocytes arranged in rows surrounded by ECM composed of aggrecan and
collagen types I, II, and III 93. This zone is avascular and functions as a force damper, dissipating
stress generated by bending collagen fibers in the tendon93. The third zone is avascular, calcified
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fibrocartilage with hypertrophic fibrochondrocytes and ECM composed of aggrecan and collagen
types II and X93,94. The third zone is at the boundary with subchondral bone and is highly
irregular, providing mechanical integrity through the attachment of the mineralized layer to the
bone93. Some studies suggest that this zone is important for blocking blood supply from reaching
the avascular zones in the enthesis and tendon/ligament, preventing communication between the
compartments93. The fourth zone is the bone proper, characterized by populations of osteoblasts,
osteoclasts, and osteocytes residing in a disorganized ECM of type I collagen and
hydroxyapatite93.

Figure 2: Schematic representation of the enthesis, depicting the different zones and the gradients of cells, extracellular matrix,
and signaling molecules exhibited in the transition from tendons/ligaments to bone tissues.

Though the four zones exhibit clear compositional and functional differences, it needs to
be stressed that the structure is continuous and the gradient contributes greatly to the function of
the tissue93–96. The development of these zones occurs postnatally, although the exact process is
poorly understood. A combination of physicochemical stimuli drive the gradient formation in the
interfacial structure94–96. Transcription factors Sox9 and Scleraxis (Scx) play important roles in
the development of the enthesis, and are arranged in countergradient fashion in immature
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postnatal entheses94. Scx is associated with tenogenesis, while Sox9 is widely accepted to drive
chondrogenesis. The primitive enthesis is composed of a pool of progenitor cells that express
both transcription factors (Scx+/ Sox9+), and progressively polarizes to include a pool of Scx/Sox9+ and Scx+/Sox9- cells94,96. The development of the Scx and Sox9 countergradient is
believed to be stimulated by transforming growth factor-β (TGF-β) as well as mechanical forces
acting on the enthesis95. These stimuli are both present during healing responses, but it is not yet
understood why the result is fibrous scar tissue without the functional structure of the
enthesis94,96. Several studies have focused on the use of other growth factors for enthesis
regeneration, with platelet-derived growth factor (PDGF) and bone morphogenetic growth
factor-2 (BMP-2) garnering great attention97–101. PDGF-B has been associated with
ligament/tendon regeneration both in vitro and in vivo97–99. BMP-2 has been widely used for
bone regeneration97,100,101. Both growth factors have been FDA approved for clinical use, and in
a preclinical study where a gradient of BMP-2 and PDGF-B was immobilized in a porous
membrane, they directed mesenchymal stem cell (MSC) differentiation in vitro to recreate
gradient structures97. While this study is promising, the use of recombinant proteins presents
several challenges: high cost, handling difficulty, supraphysiological dosages, and less
effectiveness than paracrine, endogenous stimulation. The adult enthesis has no native
populations of stem cells in the tendon/ligament portion, but the presence of osteoblastic
precursors is evident in the bone zone96. This lack of stem cells and the poor vascularization of
the enthesis zones 1-3 partially explain the lack of proper healing95. Most current studies that
focus on cell-based strategies for enthesis regeneration use MSCs (bone marrow and adiposederived) due to their relative abundance, ease of expansion, and ability to differentiate into the
cells that populate the native enthesis93–96.
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A potential optogenetic tissue engineering strategy is presented in which an electrospun
template (component 1) will be used to deliver physicochemical cues to engineered cells
(component 2) to generate an opposed gradient of growth factors that will guide the regeneration
of the structural and functional characteristics of the enthesis. To accomplish this goal,
engineered cells with synthetic gene regulatory networks constructed with CRISPR-based logical
gates, respond to the stimuli presented by the template. Details regarding this strategy are
presented in chapters 4 and 5.
In this dissertation, the successful development of an optogenetic CRISPR/Cas tool that
unleashes the full functionality of the CRISPR toolset will be described. Furthermore, the
development of air gap electrospun templates that can deliver gradients of blue light to cells for
spatiotemporal regulation will be discussed. Finally an optogenetic synthetic biology approach
incorporating both of the elements defined above will be proposed, and preliminary work leading
to this goal will be presented.
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CHAPTER 2
SPECIFIC AIMS AND MOTIVATION

The purpose of this work was to develop a novel system for optogenetic control of
CRISPR/Cas systems that enables precise spatiotemporal regulation of any Cas and relevant
functional variants, and to showcase the versatility and utility of such a system through a novel
strategy for morphogen gradient production for tissue engineering of the enthesis. It is
hypothesized that a versatile, fully orthogonal optogenetic CRISPR/Cas system will enable
researchers to address many important biological questions across different fields and further
progress towards therapeutic interventions. To achieve this, focus was placed on three specific
aims:
1. Develop an optogenetic gRNA production system and test its compatibility with
different Cas9 functions, and other Cas types.
2. Investigate the potential of delivering a gradient of blue light via an air gap
electrospun template.
3. Develop an optogenetic CRISPR/Cas-based digital demultiplexer circuit to enable the
generation of opposing gradients of BMP-2 and PDGF in response to
physicochemical gradients for tissue engineering of the enthesis.
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CHAPTER 3
OPTOGENETIC gRNA EXPRESSION FOR SPATIOTEMPORAL CONTROL OF
ORTHOGONAL CRISPR/CAS SYSTEMS

CRISPR/Cas has emerged as a powerful and versatile system for controlling gene activity
and introducing precise mutations in the genome62,102,103. The original CRISPR/Cas system used
for programmable DNA cleavage is based on type II Cas9 from S. pyogenes, and has now been
supplemented with Cas proteins from other bacterial species (e.g. S. aureus and E. coli) and of
other types (e.g. Cas12, Cas13)70,71. The use of orthogonal Cas proteins may have several
advantages, including expanded target space due to alternative protospacer adjacent motifs
(PAM), targeting of RNA, and decreased size for more efficient viral delivery (SaCas9 or
LbCas12a). Importantly, spatiotemporal control of CRISPR/Cas activity addresses a level of
control necessary for exploration of new biological questions, and could be useful in future
therapeutic settings to limit unwanted CRISPR/Cas activity and regulate genomic and
epigenomic events in a precise manner78,88,104. Most current methods for spatiotemporal control
of CRISPR/Cas systems are based on light-induced dimerization of split-Cas, or dimerization of
Cas with effectors3,6,7. To expand the use of light-induced split-Cas systems to additional
functions, species, and types of Cas, e.g. base editors and Cas13, therefore requires cumbersome
engineering of new split-Cas variants. Furthermore, the availability of discrete and orthogonal
dimerizing domains is limited, further complicating the use of multiple Cas functions in a single
cell, which is desirable when constructing closed loop and synthetic gene regulatory network
systems.
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To avoid the limitations of current split-Cas systems we have generated an optogenetic
platform for light controlled expression of gRNA, allowing for complete spatiotemporal control,
multiplexing and full orthogonality. To achieve this, we have established a system for ribozymedependent expression of gRNAs from a light activated RNAPII promoter. This allowed us to
control the activity of several orthogonal Cas proteins, including activators, repressors, and base
editors, by using blue light.
To enable light-induced activation of gRNAs we took advantage of the blue lightactivated protein EL22290. Upon exposure to blue light (470nm), EL222 dimerizes and binds to
its response elements in the C120 promoter90. By fusing EL222 to a transcriptional activator,
blue light activation of EL222 leads to RNAPII mediated transcription from C120 (Figure 3a).
To allow for the production of gRNAs from an RNAPII promoter, we flanked the gRNA
sequence with hammerhead (HH) and Hepatitis delta virus (HDV) ribozymes, leading to precise
excision of the gRNA sequence from the transcript (Figure 3b)105. To track the induction of C120
by blue light in some applications, we generated a version with an mCherry reporter between the
C120 promoter and the HH-gRNA-HDV (RGR) cassette.
The current generation of EL222 activator is fused to VP16 (VP16-EL222), resulting in
moderate activation of reporter genes downstream of C120 after exposure to blue light (Figure
5)90. Importantly, the activation of VP16-EL222 by blue light did not produce sufficient amounts
of gRNA for dCas9-VPR dependent activation of endogenous genes (Figure 6). To obtain
sufficient levels of gRNA transcription, we therefore replaced the VP16 activation domain of
VP16-EL222 with the more potent VP64-p65-Rta (VPR) transcriptional activator, thus creating a
second generation of EL222 activator (VPR-EL222) (Figure 6). We then generated a plasmid for
blue light-activated universal VPR-improved production of RGRs (BluVIPR) containing VPR-
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EL222, a C120 promoter, an optional mCherry reporter, and an RGR (Figure 3c). To assess how
BluVIPR compared to traditional chemogenetic induction systems, we also generated a plasmid
for doxycycline induced expression of RGRs (Dox-RGR). The mCherry reporter was strongly
activated in both BluVIPR and Dox-RGR after exposure to blue light or doxycycline,
respectively (Figure 3d). We then tested the ability of BluVIPR and Dox-RGR to induce the
expression of endogenous genes through activation of SpdCas9-VPR, and found BluVIPR was
as potent as Dox-RGR and with significantly lower background (Figure 3e). This demonstrated
that the improved VPR-EL222 induced sufficient levels of gRNA to activate SpCas9.
In contrast to previous induced CRISPR/Cas systems, where the induction is based on
chemical or light-induced dimerization of split-Cas, or of recruitment of effector domains to
dCas9, the BluVIPR system allows for optogenetic control of genetically encoded, nonmodified
gRNAs. One major advantage of this is that BluVIPR can be easily combined with any available
Cas protein, without the need for split-Cas, recruited effector domains, or chemically modified
gRNAs. BluVIPR therefore allows for e.g. light-induced base editors, and light-induced Cas13d.
The BluVIPR system can also be introduced in cells from commercially available Cas9, dCas9SPH, and dCas9-SunTag mice, simplifying light-based control of CRISPR/Cas in primary cells
and readily available, off-the-shelf animal models. Furthermore, the BluVIPR system allows for
multiplexed induction of several gRNAs, including induction of multiple gRNAs with different
scaffolds for simultaneous activation of orthologous Cas proteins.
To prove the versatility of the system, we combined BluVIPR with SpCas9 functional
variants, and Cas proteins of different types. We first tested the ability of BluVIPR to direct
SpCas9 DNA cleavage. For this, we co-transfected a reporter cell line based on HEK293T cells
harboring a dTomato fluorescent protein that has been mutated to be out of frame and therefore
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non-functional, with an SpCas9 plasmid and a BluVIPR plasmid containing an RGR targeting a
region upstream of the dTomato transcription start site (TSS) (Figure 3f). Upon blue light
stimulation, Cas9 mediated cleavage is repaired and the most common indel (-1) restores the
reading frame and activates dTomato (Figure 3g). Furthermore, we used BluVIPR to induce the
activity of SpnCas9 base editors (Target-AID and ABEmax). HEK293T cells were used to
generate C-to-T and A-to-G base editing reporter cells by insertion of a mutated start codon (Cto-T) or a premature stop codon (A-to-G) in EGFP, which would be edited to a correct start
codon by Target-Aid or ABEmax and allow expression of EGFP (Figure 3h)106,107. After
exposure to blue light, flow cytometry data shows a population of cells with both mCherry and
EGFP expression, evidence of optogenetic base editing (Figure 3i). Fluorescence microscopy
confirms the presence of EGFP in cells with targeting gRNA that have been stimulated by blue
light (Figure 3j).
A major advantage of the BluVIPR system is the ability to use orthogonal Cas proteins of
different types. To prove this, we used the BluVIPR system to activate the Type V Cas12a to
activate endogenous PDGFB transcription (Figure 3k)74. In HEK293T cells that have been
transfected with BluVIPR and stimulated with blue light, PDGFB levels are around 4-fold higher
than in cells that remained in the dark.
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Figure 3: BluVIPR as an orthogonal optogenetic CRISPR/Cas system: a. Schematic overview of VPR-EL222 function, b. Schematic of RGR, c. Schematic of BluVIPR
plasmid, d. BluVIPR compared to Tet-On activation of mCherry (1mW/cm2 470nm activation, 24 hours), e. BluVIPR compared to Tet-On CRISPRa activation of
BMP-2 (1mW/cm2 470nm activation, 24 hours, n=3), f. Schematic of dTomato reporter for Cas9 nuclease function, g. BluVIPR activation of Cas9 nuclease reporter
cells, top right panel shows edited cells; NTC: Non-target Control(1mW/cm2 470nm activation, 24 hours, imaged 48 hours post stimulation), h. Schematic of C-to-T
Base Editing reporter, i. BluVIPR activation of C-to-T and A-to-G base editors (1mW/cm2 470nm activation, 24 hours) top panels show mCherry expressing cells and
a distinct double positive population of edited cells, j. BluVIPR activation of C-to-T base editor (1mW/cm2 470nm activation, 24 hours, cells imaged 48 hours post
stimulation), k. BluVIPR activation of dCas12a-VPR results in 4-fold activation of PDGFB upon light stimulation (1mW/cm2 470nm activation, 48 hours).
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The versatility of light-induced gRNA expression also allows for spatiotemporal control
of orthologous Cas proteins in vivo. To demonstrate this, we used zebrafish embryos (3 days post
fertilization) to demonstrate spatiotemporal control of precise base editing in vivo. HEK293T Cto-T base editing reporter cells were transfected with Target-Aid and BluVIPR expressing a
gRNA designed to activate C-to-T base editing, and subsequently injected into the zebrafish yolk
sack (Figure 4a). By illuminating a spatially defined region of the zebrafish embryo, we could
activate the base editor reporter (EGFP), confirmed by light-sheet microscopy (Figure 4b). To
demonstrate the compatibility of BluVIPR with commercially available CRISPR/Cas mouse
models, we used neural stem cells (NSCs) from Cas9 mice (Gt(ROSA)26Sor
EGFP)Fezh

tm1.1(CAG-cas9*,-

) to optogenetically target EGFP (Figure 4c). The NSCs from these mice

constitutively express SpCas9 and EGFP. We transfected murine NSCs with BluVIPR
containing an EGFP-targeting RGR and upon exposure to blue light, Blue-light induced
activation of mCherry reporter was evidenced (Figure 4d).
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Figure 4 BluVIPR is active in vivo: a. Schematic of zebrafish experiment, C-to-T reporter cells were injected into yolk sack and stimulated with Light Sheet
microscope (2 minute activation, continual scanning of yolk sack with 488nm laser, followed by 10 minutes of darkness, repeated for 5 cycles), embryos were imaged
with light sheet microscope 24 hours post stimulation, b. C-to-T reporter cells exhibit mCherry and EGFP, indicating both BluVIPR activation of mCherry and base
editor activity, c. Schematic of Mouse NSC experiment, NSCs were isolated from Cas9 mice, transfected, and stimulated (1mW/cm2 470nm activation, 24 hours) then
imaged 24hours post stimulation.
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In summary, the overall data presented indicates an efficient system for optogenetic
control of gRNA expression, allowing for complete spatiotemporal control, multiplexing and
fully orthogonal CRISPR/Cas regulation. This system can be used to optogenetically activate
different SPCas9 variants and even other species and type of Cas. The ability to harness the full
spectrum of CRISPR/Cas tools with an optogenetic means of control opens up many exciting
avenues of research and has potential therapeutic implications. Such a system has uses in
virtually any imaginable genome, epigenome, or transcriptome engineering application where
precise spatiotemporal regulation is desired.

ADDITIONAL INFORMATION
METHODS
Cell culture
HEK293T (Espinosa laboratory stock) were cultured in high-glucose DMEM (Sigma
Aldrich) supplemented with fetal calf serum (10%), streptomycin (0.1 mg/ml), penicillin (100
U/ml), Sodium pyruvate (1 mM) (Sigma Aldrich), HEPES (10 mM) (Sigma Aldrich) and Lglutamine (2 mM) (Sigma Aldrich). Cells were routinely tested for mycoplasma contamination.
Transfections of HEK293T cells were performed using X-tremeGENE 9 DNA Transfection
Reagent (Roche). All experiments/transfections were performed in triplicate.

Plasmid constructs
pRS0045 (Addgene #131124)
pRS0035 (Addgene #131125)
lentiCRISPR v2 (Addgene #52961)
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pLV-SI-121 (Addgene #131126)
pLV-SI-112 (Addgene #131127)
pCMV_ABEmax (Addgene #112095)
pXR001 (Addgene #109049)
pSBtet-GB (Addgene #60504)
gRNA-Cloning (Addgene #41824)
SP-dCas9-VPR (Addgene #63798)
CRISPR-SP-Cas9 reporter (Addgene #62733)
BluVIPR plasmids will be deposited to Addgene.
Gene fragments were synthesized (GeneStrands, Eurofins; gBlocks, IDT). Gene synthesis
was performed by Eurofins. Some fragments from existing constructs were replicated with PCR
using Platinum Pfx DNA polymerase (ThermoFisher). Constructs were assembled by Gibson
assembly (Gibson Assembly® Master Mix (New England Biolabs)) and golden gate assembly.
All assembled constructs were verified by Sanger sequencing and restriction digests.
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Table 1 gRNA sequences
gRNA Target

Sequence

dTomato Reporter

GGGCCACTAGGGACAGGAT

Cas 9 NTC

GAACGACTAGTTAGGCGTGTA

BMP-2

GGCGAGCCGCGCCGCGAAGG

C-to-T reporter

CACGGTCACCCTGACACGCT

A-to-G reporter

CCTTATGACCCTGACACGCT

Cas12a PDGFB

TAAAGGAGAAGGGAGAGTGCGAG

Cas12a NTC

GAACGACTAGTTAGGCGTGTA

Optogenetic experiments
BluVIPR activity assay
HEK293T cells were seeded in black walled, optical bottom 96 well plates (Thermo
Scientific, 165305) at 40,000 cells/well. Cells were transfected with BluVIPR plasmid (50ng)
immediately after seeding. 24 hours after transfection, cells were stimulated with 1mW/cm2 of
470nm light on a custom made transilluminator. Fluorescence micrographs were taken on a Zoe
fluorescent cell imager (Bio-rad) after 24 hours of stimulation.

BluVIPR CRISPRa assay
HEK293T cells were seeded as described for BluVIPR activity assays and transfected
with SP-dCas9-VPR and BluVIPR plasmids with targeting and non-targeting gRNA RGRs (all
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gRNA sequences are described in table 1) (50ng of each). Cells were stimulated after 24 hours
with 1mW/cm2 of 470nm light and harvested 24 hours later for RNA extraction and qPCR.

SPCas9 and Base Editor Reporter cell line generation
HEK293T cells were seeded in 6 well plates (2x105 cells/well) and transduced with 25µl
of lentiviral vectors (CRISPR-SP-Cas9 reporter, pLV-SI-121, or pLV-SI-112). Puromycin
selection (2.5µg/ml) was started 48 hours post-transduction. Surviving colonies were kept under
selection pressure and used for further experiments after 7 days.

SPCas9 reporter assay
SPCas9 reporter cells were seeded as described for BluVIPR activity assays and
transfected with lentiCRISPR v2 and BluVIPR plasmids with targeting and non-targeting gRNA
RGRs (50ng of each). Cells were stimulated after 24 hours with 1mW/cm2 of 470nm light.
Fluorescence micrographs were taken on a Zoe fluorescent cell imager (Bio-rad) after 48 hours
of stimulation.

Base Editor Assays
Base editor reporter cells were seeded as described for BluVIPR activity assays and
transfected with pCMV_ABEmax/ pRS0035 and BluVIPR plasmids with targeting and nontargeting gRNA RGRs (50 ng of each). Cells were stimulated after 24 hours with 1mW/cm2 of
470nm light. Cells were harvested for flow cytometry 24 hours later (Gallios Flow cytometer,
Beckman Coulter), or kept in the dark after stimulation and fluorescence micrographs were taken
on a Zoe fluorescent cell imager (Bio-rad) after 48 hours.
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BluVIPR CRISPRs Cas12a-VPR
HEK293T cells were seeded as described for BluVIPR activity assays and transfected
with LB dCas12a-VPR (3ng), BluVIPR plasmids with targeting and non-targeting gRNA RGRs
(70ng of each). Cells were stimulated after 24 hours with 1mW/cm2 of 470nm light, and
harvested 48 hours later for RNA extraction and qPCR.

Zebrafish imaging
Base editor reporter cells were seeded in T75 flasks (2x106cells per flask) and allowed to
grow to 70-80% confluence. Cells were transfected with pRS0035 and BluVIPR vector with
targeting gRNA (5 µg each) and kept in the dark overnight. Cells were harvested and
resuspended in 2% w/v Polyvinylpyrrolidone (Sigma) in PBS. Cells were injected into the yolk
sack of 3 days post fertilization zebrafish embryos (n=3). After 12 hours, embryos were
stimulated with a Carl Zeiss Z.1 lightsheet microscope (2 minute activation, continual scanning
of yolk sack with 488nm laser, followed by 10 minutes of darkness, repeated for 5 cycles), then
kept in the dark. Embryos were imaged 24 hours after stimulation with the same microscope.

Mouse NSCs
The subventricular zone (SVZ)-derived neural progenitor cells (NPCs) were isolated
according to a modified protocol by Johansson et al. (1999)108,109. Briefly, SVZ biopsies were
isolated and the cells dissociated. For isolation of the NPCs, mechanical and enzymatic
dissociation using 200 U/ml DNase (Sigma-Aldrich) and 10 U/ml papain (Worthington) was
used. The cells were washed in 0.9 M sucrose in Hanks balanced salt solution (Invitrogen) to
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remove the myelin debris. The cells were cultured in propagation medium, composed of
DMEM/F-12 containing B27 supplement (Invitrogen), penicillin (100 U/ml), and streptomycin
(100 µg/ml) (Invitrogen), 20 ng/ml epidermal growth factor (EGF, Sigma-Aldrich), and 20 ng/ml
basic fibroblast growth factor (bFGF, R&D systems).
Cells were electroporated with BluVIPR with gRNA targeting EGFP. Cells were
stimulated after 24 hours with 1mW/cm2 of 470nm light. Fluorescence micrographs were taken
on a Zoe fluorescent cell imager (Bio-rad) and subsequently cells were harvested for flow
cytometry 24 hours later (Gallios Flow cytometer, Beckman Coulter).
Luciferase assays
We used X-tremeGENE 9 (Roche) to transfect HEK293T cells in 96-well plates (40,000
cells/well, 50ng per construct). pRL-CMV-Renilla (5ng) for normalization. Luminescence was
measured 24 hours post-transfection using the Modulus Single Tube Reader (Promega). Relative
luminescence (RLU) is reported as firefly (Photinus) luciferase signal divided by Renilla
luciferase signal.

Quantitative PCR
All RNA extractions were performed using TRIzol (Invitrogen). cDNA conversions were
performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) or
the iScript cDNA Synthesis Kit (Bio-Rad). Gene expression was determined using TaqMan gene
expression assays (Thermo Fisher Scientific): PDGFB (Hs00966522_m1), HPRT1
(Hs01003267_m1), BMP2 (Hs00154192_m1). The reactions were performed using the Light
Cycler 96 real-time PCR system (Roche), and data were analyzed using the Light Cycler 1.1
software (Roche).
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Statistical analysis
Statistical analyses were performed using R (R 3.4.4) or Prism 6 (GraphPad Software).
One-way ANOVA and post-hoc Tukey tests were performed to assess significance, with p<0.05.
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SUPPLEMENTARY
EL222 activation
HEK293T cells were seeded in black walled, optical bottom 96 well plates (Thermo
Scientific, 165305) at 40,000 cells/well. Cells were transfected with EL222-Luc (50ng) and pRLCMV-Renilla (5ng) for normalization. Luminescence was measured 24 hours post-transfection
using the Modulus Single Tube Reader (Promega). Relative luminescence (RLU) is reported as
firefly (Photinus) luciferase signal divided by Renilla luciferase signal. Modest activation of
Luciferase was evidenced after blue light stimulation (fig 3).

Figure 5 VP16-EL222 activation of Luciferase reporter. EV: Empty vector control.

BluVIPR vs VP16-EL222
HEK293T cells were seeded in black walled, optical bottom 96 well plates (Thermo
Scientific, 165305) at 40,000 cells/well. Cells were transfected with BluVIPR or EL222mCherry plasmid (50ng) immediately after seeding. 24 hours after transfection, cells were
stimulated with 1mW/cm2 of 470nm light on a custom made transilluminator. Fluorescence
micrographs were taken on a Zoe fluorescent cell imager (Bio-rad) after 24 hours of stimulation.
Robust expression of mCherry was evidenced in the BluVIPR groups (Figure 6).
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Figure 6 BluVIPR vs VP16-EL222
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CHAPTER 4
AIR GAP ELECTROSPUN TEMPLATES WITH BLUE LIGHT GRADIENT FOR
ENGINEERED CELL STIMULATION
INTRODUCTION
Anterior cruciate ligament reconstruction surgery has high repair failure, mostly due to
the current inability to regenerate a properly functioning enthesis93. The specialized interface
referred to as the enthesis, the insertion of tendons/ligaments into bone, is a highly-organized
tissue presenting continuous gradients of structural and mechanical properties that allow smooth
force transfer, protecting and maintaining the tendon/ligament insertion. The mechanical
properties of the enthesis arise from a gradient of cell type/morphology, extracellular matrix
(ECM), and minerals that transition smoothly from tendon/ligament to bone (Figure 7). The lack
of regeneration of the enthesis leads to high failure rates after these procedures due to formation
of a discrete transition of tissue characteristics which acts as a force concentrator that, under
mechanical loading, is the site of rupture. The structural and mechanical gradients of entheses are
critical for normal function and regenerating these gradients is a major challenge. Here we
present a possible strategy for utilization of an air gap electrospun template delivering a blue
light gradient to engineered cells to promote growth factor production as an interfacial tissue
engineering approach.
The development of the enthesis occurs postnatally, although the exact process is poorly
understood. A combination of physicochemical stimuli drive the gradient formation in the
interfacial structure. Transcription factors Sox9 and Scleraxis (Scx) play important roles in the
development of the enthesis, and are arranged in opposing gradient fashion in immature postnatal
entheses (Figure 7). Previous studies have reported that arranging growth factors on porous
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membranes in opposed gradients leads to differentiation of progenitor cell populations and
arrangement of structural properties reminiscent of a native enthesis97.

Figure 7 Schematic of enthesis structural gradient and growth factor opposed gradients that give rise to the entheseal tissue
characteristics.

Electrospinning is a popular process for nanofiber production, leading to porous
membranes, involving a charged polymer solution jet collected on a grounded target110.
Typically, electrospun templates are randomly deposited, non-woven fibers, but several
approaches can be used to generate spatially organized fibers110,111. Air gap electrospinning uses
equidistant grounded targets separated in space to collect fibers, resulting in aligned structures
that mimic the native ligament111,112. Air gap electrospinning is thus a viable technique to
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produce templates with highly aligned fibers that promote appropriate cellular morphology,
function, organization, and infiltration111. Electrospun templates made of polycaprolactone
(PCL) are widely used in tissue engineering, and their degradation and biocompatibility
characteristics are well known111. Furthermore, aligned nanofiber templates have been shown to
promote tendon-like tissue formation, which would be exploited for development of the tendon
proper along the template, changing in a gradual fashion towards a bone tissue when
approaching a light source93,97,111.
For the development of the delivery of gradient stimuli, we chose blue light, expecting
diffusion through the template according to Beer-Lambert's Law. The hypothesis is that by
illuminating an aligned-fiber electrospun scaffold on one end, the light will generate a gradient in
the template longitudinal axis. The light dose is thus titrated in a smooth gradient and can be
used to stimulate cells to produce growth factors following this gradient. A wide variety of
optogenetic tools are being developed and could be used to engineer the cells to be used with
these templates75,76,90,92. In this initial study, we present the development of air gap electrospun
PCL templates that emulate tendon or ligament morphology and mechanical properties.
Furthermore, we describe the generation of a blue light gradient in a physiologically-relevant
scale for enthesis regeneration, through the potential stimulation of engineered cells that would
deposit growth factors in gradient fashion, mimicking entheseal development.
MATERIALS AND METHODS
ELECTROSPINNING
Polycaprolactone (MW 80,000; 440744; Sigma) was dissolved overnight in 1,1,1,3,3,3
hexafluoro-2-propanol (HFP, Oakwood Products) at 100 mg/ml concentration. Electrospinning
parameters were +25KV, 10 cm distance from needle to collection targets, 5 cm air gap between
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collection targets, 3 ml/hr flow rate through an 18 gauge blunt needle, and collected on a rotating
air gap mandrel. Airgap electrospinning apparatus was based on the system described by Sell et
al., and was 3D printed in-house from polylactic acid filament111. Templates were allowed to dry
in desiccator at room temperature for at least 24 hours before any subsequent experiments.
NANOFIBER MEASUREMENT
Templates were imaged using scanning electron microscopy (SEM, FEI NN650 FEG,
Noca NanoSEM with field emission gun) at +20kV, working distance of 5mm, and 1,000X
magnification, and fiber diameter was measured with FibraQuant 1.3 software (NanoScaffold
Technologies) (n=3). Average fiber diameter was calculated using 300 random measurements
per template. Computer-generated measurements were checked visually to ensure accurate
diameter of fibers were measured, and that few or no repeated measurements were analyzed.
MECHANICAL TESTING
Uniaxial tensile testing was performed on dog-bone shaped samples (2.75mm at
narrowest width, 7.5mm gauge length), using a TestResources frame (model: 220Q). Samples
(n=5) were allowed to proceed to failure at a strain rate of 10mm/min. Force -Elongation curves
were recorded with XY software (TestResources).
BLUE LIGHT GRADIENT CHARACTERIZATION
To analyze the gradient in blue light intensity along the longitudinal axes of the
templates, samples (n=5) were illuminated from one end with an OpalDrive laser source (470nm
wavelength; 20mW, Ellumiglow) and Laser Wire guide (Ellumiglow) and images acquired with
a Pariss Imaging Microscope (LightForm). A path was drawn from the edge of the sample, and
the intensity of each pixel along this path was calculated with ImageJ software, and plotted along
the longitudinal axis.
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RESULTS
Templates had an average fiber diameter of 519±120nm. Fibers were aligned and
presented similar morphology to ligament ECM (Figure 8)113. Noteworthy are the undulating
fibers, similar to the crimped (relaxed) structure in native tendon/ligament collagen fibrils. It is
likely that the mechanical shock absorber function these undulating structures play in native
tissues would be replicated by to the air gap electrospun templates. To test this, we performed
mechanical testing on the templates.

Figure 8: Representative SEM micrograph of air gap electrospun PCL templates compared to native pig ACL enthesis. On the
left is a pig ACL enthesis (l. Zhao, et al.), on the right is a representative image of our templates.

Uniaxial tensile testing showed that templates exhibit similar characteristics to natural pig
ligament, albeit with less ultimate stress at failure114. Particularly interesting is the presence of an
initial concave area, a linear range, and initial failure point in the stress-elongation curves (Figure
9). The ultimate stress at failure was 28000±2500 KPa.
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Figure 9: Representative Stress-Elongation curve for air gap electrospun templates compared to native ligaments. On the left is a
force-elongation curve from tensile strength test on pig ligaments (S. Pal et al., 2014). On the right is a representative curve from
our templates.

Templates were illuminated with the OpalDrive laser source and Laser Wire guide in
direct contact and perpendicular to the longitudinal axis of the template. The laser wire is 900µm
in diameter and was affixed directly adjacent to the template on a clear cover slip. The
single power setting on the laser source module consistently casted light through the fibers, and a
light gradient was readily apparent under microscopic observation. Blue light gradients were
exhibited on the first 400±100µm of the template, and correspond to the desired range of
enthesis depth - 200-500µm (Figure 10).
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Figure 10: Representative pixel intensity plot along template longitudinal axis. On the left is a representative micrograph of the
blue light gradient on our templates. Point 1 (225um) is estimated 50% intensity point as measured by the Pariss Imaging
Microscope.

DISCUSSION
The fibers generated with the air gap electrospinning setup were of appropriate diameter,
aligned and showed undulating patterns that closely resemble native tissue ECM. The similarity
to the natural substrate should allow engineered cells to attach and flourish on and in the
templates. Ultimate stress at failure was significantly lower for the templates than what is
reported in literature for native ACL (35 MPa)115. This could be explained by the thickness of the
tested samples (average of 0.05mm). Thicker templates could likely increase the ultimate stress
at failure. Regardless, the shape of the stress-elongation curves show similar important structural
properties to native ACL.
The blue light gradients exhibited on the templates behaved as expected for the
presentation of cues to engineered cells in ACL regeneration strategies that we propose. The
intensity of light, and subsequent gradient generation and depths, could be tailored with the use
of a variable power output laser source. Light gradient properties could also be modulated
through material composition and fiber characteristics through electrospinning parameter
manipulation. Altogether, the data presented shows that air gap electrospun templates have
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biomimetic characteristics (morphological and mechanical) and are amenable to the generation
of a blue light gradient for optogenetic stimulation of growth factor production by engineered
cells. This combination should be useful in the directed differentiation of cells to populate the
enthesis. This study is the first to elucidate the possibility of presenting engineered cells with
blue light stimulation in a gradient fashion for interfacial tissue engineering, and is a proof of
concept of how the templates could deliver these stimuli.
CONCLUSION
Biomaterial-mediated optogenetics could provide an alternative approach to
spatiotemporal patterning of growth factors for tissue engineering, and would be of special
interest to interfacial tissue regeneration, as recapitulating the gradient nature of interfaces is a
challenging goal for regenerative medicine. This work presents a proof of concept for how
electrospun templates could be used as vehicles for gradient stimulation of engineered cells with
blue light. This is a first step towards characterizing how light interacts with electrospun fibers,
providing a springboard for future development of integrated systems with engineered cells.
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CHAPTER 5
CRISPR/CAS-BASED DIGITAL DEMULTIPLEXER CIRCUIT TO GENERATE
COUNTER-OPPOSED GRADIENTS OF GROWTH FACTORS FOR INTERFACIAL
TISSUE ENGINEERING
INTRODUCTION
The enthesis, as an example of an interfacial tissue, arises in embryonic development
through the generation of counter-opposed gradients of growth factors that direct an arrangement
of cells, signals, and extracellular matrix93,94. The specialized interface referred to as the enthesis,
the insertion of tendons/ligaments into bone, is a highly-organized tissue presenting continuous
gradients of structural and mechanical properties that allow smooth force transfer, protecting and
maintaining the tendon/ligament insertion93,94,96. The lack of regeneration of the enthesis leads to
high repair failure rates, due to formation of a discrete transition of tissue characteristics which
acts as a force concentrator that, under mechanical loading, is the site of rupture93. Tissue
engineering approaches that mimic the developmental process of polarization of a pool of
progenitor cells through growth factor counter-gradients could be a promising approach to
regenerate entheseal structures. Though the presentation of signals in appropriate spatiotemporal
patterns is a fundamental concept of tissue engineering, current strategies rely heavily on the use
of recombinant proteins and fabrication strategies to present these proteins to cells100,116,117.
These recombinant proteins must often be delivered in supraphysiological doses that increase
cost and potential side effects116–118. A solution that utilizes simple, genetically-encoded,
synthetic gene regulatory networks could provide an elegant means of directing cell production
of endogenous growth factors with easily controlled and cost-effective physico-chemical stimuli.
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In this chapter, we discuss the concept and preliminary work towards building such a solution: a
chemo-optogenetic, CRISPR/Cas-based digital demultiplexer circuit.
CRISPR/Cas systems are RNA-guided restriction machineries that evolved as primitive
acquired immune systems in prokaryotes62,102. Bacteria and archaea utilize this machinery to
defend themselves against mobile genetic elements, such as phages. In this evolutionary arms
race, phages have responded by evolving small proteins that hinder CRISPR/Cas mechanisms:
Anti-CRISPR proteins (Acr)119,120. These Acr are highly specific, and show great affinity for
their targets. Both CRISPR and Anti-CRISPR elements have been utilized to develop tools for
genome engineering, and form the basis for the demultiplexer circuit described here121.
A demultiplexer is a circuit that uses a data input and one, or multiple, selection inputs to
assign values to outputs depending on the selection inputs122. If the data input is constant, the
selection input can influence the outputs in opposite functions (like an OR gate), allowing the
demultiplexer to act as a binary decoder122. This effectively converts a serial signal into a parallel
output, allowing for one stimulus to have multiple effects, depending on design. The
demultiplexer described in this chapter uses doxycycline (or transcription from constitutive
promoters) as a constant data input, and blue-light (470nm) as a selection input. BluVIPR, as an
optogenetic control system allowing for transcription of both protein-encoding sequences and
gRNA, is the tool that allows to switch the selection input into a binary code. The BluVIPRmediated, light-induced production of gRNA specifically targets one growth factor
transcriptional regulation sequence for activation (BMP-2) via SPdCas9, while upstream of the
RGR, an Acr-encoding sequence (AcrVa1) specifically targets LBdCas12a. In the complete
circuit, detailed in Figure 11, LBdCas12a-VPR is targeted to activate transcription of another
growth factor (PDGFB). This logic allows blue light to activate transcription and production of
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BMP-2, and simultaneously inhibit the CRISPRa activation of PDGFB. Based on data that
suggests that counter-opposed gradients of bone morphogenetic protein 2 (BMP-2) and platelet
derived growth factor B (PDGFB) can drive differentiation recapitulating the cellular and
extracellular matrix distribution of entheses, we chose to use these growth factors as targets for
the outputs of the circuit97. Utilizing this demultiplexer, cells that have been programmed will
respond to a gradient of blue light by producing counter-opposed gradients of BMP-2 and
PDGFB, driving polarization and mimicking the developmental conditions that give rise to
entheseal structures.

Figure 11 Schematic of BluVIPR digital demultiplexer circuit and the growth factor opposing gradients formed in response to a
blue light gradient.
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MATERIALS AND METHODS
Cell culture
HEK293T (Espinosa laboratory stock) were cultured in high-glucose Tet-approved
DMEM (Sigma Aldrich) supplemented with fetal calf serum (10%), streptomycin (0.1 mg/ml),
penicillin (100 U/ml), Sodium pyruvate (1 mM) (Sigma Aldrich), HEPES (10 mM) (Sigma
Aldrich) and L-glutamine (2 mM) (Sigma Aldrich). Cells were routinely tested for mycoplasma
contamination. Transfections of HEK293T cells were performed using X-tremeGENE 9 DNA
Transfection Reagent (Roche). All experiments/transfections were performed in triplicate.

Plasmid constructs
Lenti-EF1a-dCas9-VPR-Puro (Addgene #99373)
SP-dCas9-VPR (Addgene #63798)
PB-TRE-dCas9-VPR (Addgene #63800)
pRL-CMV-Renilla (Promega)
BMP-2 Luciferase reporter (SwitchGear Genomics)
gRNA cloning vector (Addgene #41824)
BluVIPR and demultiplexer plasmids will be deposited to Addgene.
Gene fragments were synthesized (GeneStrands, Eurofins; gBlocks, IDT). Gene synthesis
was performed by Eurofins. Some fragments from existing constructs were replicated with PCR
using Platinum Pfx DNA polymerase (ThermoFisher). Constructs were assembled by Gibson
assembly (Gibson Assembly® Master Mix (New England Biolabs)) and Golden Gate assembly.
All assembled constructs were verified by Sanger sequencing and restriction digests.
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gRNA screens
The sequences used for all the gRNA screens were designed with the Genetic
Perturbation Platform’s sgRNA Designer webtool (Broad Institute). Sequences were chosen to
target 75 to 300 base pairs upstream of the target gene’s TSS, using the Human GRCh38
reference genome, and respective Cas to be used (SPCas9 (NGG PAM) or LBCas12 (TTTV
PAM)).
We used X-tremeGENE 9 (Roche) to transfect HEK293T cells in 96-well plates (40,000
cells/well) SP-dCas9-VPR (50ng), gRNA cloning vector (50ng) (all gRNA sequences are
described in table 1), BMP-2 luciferase reporter (50ng), and pRL-CMV-Renilla (5ng) for
normalization. Luminescence was measured 24 hours post-transfection using the Modulus Single
Tube Reader (Promega). Relative luminescence (RLU) is reported as firefly (Photinus) luciferase
signal divided by Renilla luciferase signal.
Optogenetic experiments
BMP-2 AND gate
HEK293T cells were seeded in black walled, optical bottom 96 well plates (Thermo
Scientific, 165305) at 40,000 cells/well and transfected with PB-TRE-dCas9-VPR and BluVIPR
plasmids with targeting and non-targeting gRNA RGRs (50ng of each). Cells were stimulated
after 24 hours with 1mW/cm2 of 470nm light on a custom made transilluminator and
Doxycycline (2. 5µg/ml), in combinations according to AND gate logic (-/-, +/-, -/+, +/+) and
harvested 24 hours later for RNA extraction and qPCR.
Promoter Comparison for SPdCas9VPR
HEK293T cells were seeded as described for BMP-2 AND gate experiments and
transfected with SP-dCas9-VPR/lenti-EF1a-dCas9-VPR-Puro and BluVIPR plasmids with
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targeting and non-targeting gRNA RGRs (50ng of each). Cells were stimulated after 24 hours
with 1mW/cm2 of 470nm light and harvested 24 hours later for RNA extraction and qPCR.
RESULTS
BMP-2 CRISPRa gRNA screen
Ten different SPCas9 gRNA sequences targeting upstream of the TSS of BMP-2 were
screened to evaluate activation of transcription via SPdCas9-VPR. While most of the gRNAs
exhibited strong activation of the luciferase reporter, three gRNA sequences failed to induce any
significant activation (Figure 12). Sequence number two (GGCGAGCCGCGCCGCGAAGG)
showed the highest activation, and was chosen for subsequent experiments.

Figure 12 gRNA sequence screen for SPdCas9-VPR activation of BMP-2

BMP-2 AND gate
A chemo-optogenetic AND gate, responding to blue light and doxycycline, was
generated to drive BMP-2 transcription activation (Figure 13). Two plasmids were used, a TetOn plasmid driving SPdCas9-VPR under doxycycline control, and a BluVIPR plasmid driving
gRNA production under blue light control. Cells that were exposed to both blue light and
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doxycycline exhibited strong activation of BMP-2 (Figure 13). Cells that were in the dark, or
only exposed to doxycycline, exhibited low levels of background BMP-2 production. Notably,
cells that were only exposed to blue light exhibited a high production of BMP-2, suggesting that
the leakiness of the Tet-On promoter was allowing for a significant level of SPdCas9VPR to be
present in basal conditions, without doxycycline stimulus.

Figure 13 Blue Light and Doxycycline responsive AND gate for BMP-2 production

Promoter comparison for SPdCas9-VPR
To investigate if lower basal levels of SPdCas9-VPR would lead to lower background
levels, a comparison of CMV and EF1a promoters was performed. When combined with lightinducible gRNA, EF1a exhibited a lower activation, a conserved dynamic range, and a lower
background BMP-2 level (Figure 14). These data suggest that lower SPdCas9-VPR levels indeed
lead to lower background levels.
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Figure 14: CMV vs EF1a promoters for Cas9 transcription and BluVIPR activation of BMP-2.

PDGFB gRNA Screen
Eight different LBCas12a gRNA sequences targeting upstream of the TSS of PDGFB
were screened to evaluate activation of transcription via LBdCas12a-VPR. While four of the
gRNAs exhibited strong activation of the target gene, four gRNA sequences failed to induce any
significant activation (Figure 15).
Sequence number seven (TAAAGGAGAAGGGAGAGTGCGAG)
showed the highest activation, and was chosen for subsequent experiments.
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Figure 15:gRNA screen for LBCas12a-VPR activation of PDGFB.

DISCUSSION AND CONCLUSION
In this chapter we have presented the concept and preliminary work towards a simple,
genetically-encoded, chemo-optogenetic demultiplexer circuit to direct cells to produce countergradients of growth factors upon physico-chemical stimulation. In the previous chapter, we
discussed the delivery of a blue light gradient using electrospun templates. Together, these two
chapters present the tools that allow the possibility of biomaterial-mediated optogenetic
stimulation for counter-gradient growth factor production and polarization of cell populations.
The gRNA screens for SPdCas9-VPR activation of BMP-2 and LBdCas12a-VPR
activation of PDGFB showed that, while most gRNAs designed and tested showed activation of
target genes, some were clearly more active than others. It is thus important to perform these
screens for each target gene when designing these circuits.
The demultiplexer circuit can be envisioned as two AND gates that have a constant input
and another variable input, with one AND gate having an inverter on this variable input. It was
therefore important to see that, when doxycycline is constantly present, blue light effectively
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switched BMP-2 production on and off. Despite some background levels of BMP-2 mRNA
detectable in the Doxycycline +/ Light – group, the robust activation of BMP-2 upon light
stimulation allows for modulation of elements to mitigate this background to acceptable levels.
One strategy to accomplish this background reduction would be to use a less powerful promoter
to drive SP-dCas9-VPR production. The comparison of CMV vs EF1a promoters showed that
the less powerful EF1a reduced the background, while still maintaining robust light-induced
activation of BMP-2. It could also be possible to reduce the availability of SP-dCas9-VPR via
plasmid ratios in transient transfections, or by integrating the vectors into the cell genome and
controlling copy number. An attractive idea is to use safe harbor loci insertion (eg AAVS1). It
will be important to verify that, if these strategies reduce background levels even lower, the
dynamic range remains adequate, allowing for a strong upregulation of the target gene upon
optogenetic stimulation.
While the concept and data presented in this chapter are a pilot study that shows an
elegant solution to produce growth factor counter-gradients, further studies need to be conducted
to determine the response of engineered cells to light gradients and the growth factor effects on
engineered and neighboring, non-engineered, cells. Furthermore, the generation of sustained
entheseal-like organization both in vitro and in vivo needs to be investigated in the future.
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CHAPTER 6
CONCLUSIONS
The work presented in this dissertation was centered on three specific aims. The first was
to develop an optogenetic CRISPR/Cas system to enable precise spatiotemporal control of
orthogonal Cas variants. The second was to investigate the potential of delivering blue light
gradients via air gap electrospun templates. Finally, the third aim was to develop a CRISPR/Casbased, optogenetic demultiplexer circuit to enable the generation of opposing gradients of growth
factors for interfacial tissue engineering, namely the enthesis. Each of these aims were explored
and the data generated served as the basis for chapters 3 to 5 of this dissertation. Here we will
summarize the findings of each of these chapters and then integrate the information to form
cohesive, overarching conclusions regarding the work presented and how it forms a contribution
to the fields of optogenetics and tissue engineering.
Chapter 3 describes the development of BluVIPR, an optogenetic system for expression
of gRNAs to spatiotemporally regulate CRISPR/Cas activity. The strategy of utilizing gRNA as
the output of an optogenetic RNAPII promoter is novel, and allows the BluVIPR system to be
more versatile than any previous optogenetic CRISPR/Cas system described to date. We also
demonstrated that BluVIPR activation of transcription is comparable to traditional Tet-On
systems for chemogenetic inducibility, and exhibits lower background when compared to these.
As chemogenetic inducible systems have seen widespread use and have had enormous impact in
molecular biology, the comparable characteristics of an optogenetic system are auspicious, even
more so when the spatiotemporal regulation inherent to optogenetics is considered. Especially
important is that the dynamic range of BluVIPR activation is maintained across applications,
which is a most desirable characteristic of inducible systems for synthetic biology applications.

58

Furthermore, we show the use of BluVIPR with two CRISPR/Cas functionalities that have never
before been described to be controlled with optogenetic systems: SPnCas9-based base editors
and CasRx-based CRISPR RNA interference. This showcase of the flexibility of BluVIPR is
further complemented with in vivo experiments in zebrafish and Cas9 mice. It is especially
exciting to show that BluVIPR allows the use of “off-the-shelf” transgenic Cas9 mice, as this
effectively paves the way for optogenetic experiments in mouse models without the tedious and
time-consuming task of generating transgenic mice tailored to each optogenetic application. The
prospect of, for example, inducing precise, spatiotemporally-regulated, somatic mutations in
mouse models is extremely attractive for the cancer field, among others.
In Chapter 4, we describe the investigation of blue light gradient formation on air gap
electrospun templates. This first description of light forms gradients across templates that are
commonly used in tissue engineering sets a framework for the inclusion of biomaterial-mediated
optogenetics in regenerative medicine. The templates described in this chapter exhibited similar
morphology and mechanical properties to native tendons and ligaments. These biomimetic
properties should aid the formation of tendon/ligament-like tissues, and are important
considerations for any tissue engineered construct. In addition, the templates presented gradients
of blue light of comparable length to the depth of native entheses in the knee. Since the gradient
stimulation of engineered cells is predicted to produce a gradient of growth factors, the
generation of appropriately scaled light gradients is an important finding. Facile generation of
light gradients that lead to growth factor gradients is an attractive solution to the problem of
precise spatiotemporal presentation of signals to cells in tissue engineering. Approaches to this
problem are often complex, requiring advanced manufacturing techniques and the use of
expensive recombinant growth factors in supraphysiological doses, increasing cost, complexity,
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and potential side effects. Integration of a suitable, perhaps even biodegradable, light source into
well-established templates would present an elegant alternative strategy when precise
spatiotemporal patterning of growth factors is desired.
The engineered cells referred to in chapter 4 would have to include a synthetic gene
regulatory network composed of a circuit that enables the interpretation of light stimuli to
generate the opposed gradients of growth factors necessary for interfacial tissue structure
regeneration. In chapter 5, we described the conceptual design of a digital demultiplexer circuit
based on BluVIPR activation of CRISPRa and Anti-CRISPR proteins. In this design, blue light
would activate the transcription of gRNAs to target CRISPRa, effectively inducing transcription
of a growth factor (as shown in chapter 3), and, concomitantly, activate the expression of an
Anti-CRISPR protein targeting an orthologous Cas, effectively inhibiting the transcriptional
activation of another target growth factor. This behavior is consistent with combinatorial logic
attributed to a binary decoder, where the input (in this case blue light) acts as a switch to
influence two different outputs in opposing fashion. We demonstrate the creation of the basic
circuit component of this demultiplexer, a chemo-optogenetic AND gate, where blue light and
doxycycline act as inputs to drive the activation of BMP-2. We also describe the generation of an
AND gate with an inverted input (light driving Anti-CRISPR), inhibiting the activation of
PDGFB. We hypothesize that such a circuit would create polarization of engineered cells
high

towards BMP-2

/PDGFB

low

high
low
and PDGFB
/BMP-2
cells depending on light stimuli or

lack thereof, respectively. A simple, genetically-encoded synthetic gene circuit that could drive
growth factor production in a precise spatiotemporal fashion is an attractive alternative to the use
of recombinant growth factors. Such a circuit would provide a cost-efficient solution to
controlling cell function to precisely drive cellular behavior in a human-directed manner.
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As seen above, the work described in chapters 3, 4, and 5 are interesting and provide the
basis for exciting future work independently, but act together if one syncretises the findings and
developments of each of these chapters into one system for interfacial tissue engineering. In such
a system, one can envision air gap electrospun templates seeded with demultiplexer-engineered
cells being used for ACL reconstruction, for example. The gold standard surgical technique of
femoral and tibial tunnel fixation of a graft (both all-inside and outside-in techniques should be
amenable) allows for convenient placement of a light source anchored in the bone, illuminating
the template and generating a blue light gradient that dissipates towards the “ligament” portion of
the graft. This light gradient would stimulate the engineered cells, which would generate
high

opposed gradients of BMP-2 and PDGFB. The cells would polarize to BMP-2

low
/PDGFB

at the highest light intensity, driving bone regeneration. As the light intensity subsides along the
high
low
gradient, cells transition gradually towards PDGFB
/BMP-2 , creating a gradient of cell

morphology and ECM remodeling reminiscent of the native enthesis. This strategy would utilize
simple, cost-effective materials and require only minor modifications of the current surgical
reconstruction approaches.
With a modicum of imagination, similar approaches to different research questions and
therapeutic goals requiring gradients of cellular function can be envisioned. Likewise, the
flexibility of the BluVIPR system lends itself to the conceptualization and generation of other
synthetic genetic regulatory circuits, and combining these to form logic to suit diverse
applications. Furthermore, the exploration of how to use biomaterials for optogenetic control in
applications requiring spatiotemporal control could lead to more complex and varied uses. The
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proposed framework for continued development of these systems will be described in the
recommendations for future work section of this dissertation.
The successful development of an orthogonal optogenetic CRISPR/Cas system,
BluVIPR, was the centerpiece of this dissertation, and was presented alongside the supporting
evidence for biomaterial-mediated use of such a system, and the implementation of BluVIPR in a
demultiplexer circuit to drive engineered cell behavior. Overall, the impact of BluVIPR revolves
around the flexibility of this approach. We are excited to present this tool to the molecular
biology and tissue engineering communities, and await the creative uses of it to expand the
current body of knowledge.
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CHAPTER 7
RECOMMENDATIONS FOR FUTURE WORK
It is an axiom that there are no finished works in science, and every new discovery leads
to new questions, like the Hydra’s heads. Here, we propose directions for future work in both the
BluVIPR system, as well as the biomaterial-mediated optogenetic strategy.
BluVIPR
There are at least three main avenues to explore in order to improve and increase the
potential impact of the BluVIPR system. First, generation of viral vectors that enable the use of
the system with hard to transfect cells (e.g. primary cells) would greatly increase the feasibility
of using BluVIPR in varied applications. Second, establishment of software to assist final users
in the development of RGR architecture and cloning strategies into the BluVIPR constructs
would increase user-friendliness and reduce barriers to entry. Third, the generation of a BluVIPR
mouse would facilitate the use of this system with available mouse models, requiring only the
delivery of the C120 minimal promoter and the RGR sequence.
Viral Vectors
Viral vectors would benefit greatly from reduced size for efficient packaging and
increased viral titer. To this aim, we propose the development of a smaller VPR-EL222. We
would approach this by first exploring the option of using a more compact VPR, and versions up
to 60% of the size of conventional VPR have been described in recent literature and are available
through Addgene, e.g MiniVPR. The sequence for this miniature VPR would be cloned into the
BluVIPR vector and functionality would be assessed as outlined for the original system in
chapter 3. After a functioning, smaller VPR-EL222 is developed, the use of cargo-limited viruses
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like gamma retroviral vectors (e.g. Mouse Stem Cell Virus) would be an option. The next step
would be to generate lentiviral and gamma retroviral vectors and evaluate their performance.
Software
The design of RGRs has a few complicating factors, such as the Hammer Head ribozyme
complementarity requirements of downstream sequences for efficient cleavage. While a user
with experience in designing and cloning relatively complex vectors would be able to
successfully generate RGRs and implement the BluVIPR system, we envision a simple software
that would allow other users to use BluVIPR with ease. Such a program would require the end
user to design the gRNA sequence of choice with any of the available gRNA design tools. This
sequence would then be input into the graphic user interface, and variables such as species of
Cas and version of BluVIPR vector would be chosen. With this information, the program would
generate a sequence including appropriate type IIs restriction enzyme recognition sequences
(creating overhangs compatible with the BluVIPR vector specified) and a fully functional RGR
with the appropriate gRNA scaffold for the specified Cas.
BluVIPR Mouse
While cells from available Cas mice can be modified ex vivo with the viral vectors
described earlier, applications that require delivery without cells being removed from the host
would greatly benefit from the availability of a BluVIPR mouse. In such a strategy, VPR-EL222
would be integrated into a safe harbor locus (e.g. ROSA26). An efficient way of generating
knock-in mice with CRISPR/Cas9 has been described by Chu et al. (Rajewsky group) and would
be a viable option. In summary, Cas9 and gRNA RNPs are injected into blastocysts. This gRNA
targets the intronic XbaI site of ROSA26 and, when an appropriate template DNA is provided,
allows for homology directed repair to induce knock-ins in up to 50% of injected embryos. Once
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transgenic mice expressing VPR-EL222 are generated, these could be crossed with available Cas
mice to create transgenic mice that express both Cas9 and VPR-EL222. This would allow the
generation of very small (around 1kb) cargo containing C120 and RGR sequences, packagable in
even AAV vectors.
BIOMATERIAL-MEDIATED OPTOGENETICS
To expand on the proof of concept for biomaterials as optogenetic tools presented in this
dissertation, we propose the exploration of light gradient modulation by material properties, and
the investigation into other fabrication strategies and how their products interact with light. To
characterize how material properties modulate light gradients, fabrication of electrospun
templates of different biomaterials and with varying porosity, fiber morphology, and
combinations of these, followed by light gradient analysis as outlined in chapter 4 would lead to
finding conditions that affect the generation of light gradients. Using these parameters in design
of templates for biomaterial-mediated optogenetics would allow for precise control of the desired
presentation of spatiotemporal stimuli. On the other hand, exploring how other fabrication
techniques aside from electrospinning, like additive manufacturing or hydrogel production,
generate templates with different optical qualities would expand the use of optogenetic tools with
biomaterials. To this end, templates generated with different fabrication techniques would be
evaluated as outlined in chapter 4 and compared to each other to create a database of desired
material properties coupled with optical properties.

65

REFERENCES
1.

Yamada, M., Nagasaki, S. C., Ozawa, T. & Imayoshi, I. Light-mediated control of Gene
expression in mammalian cells. Neuroscience Research 152, 66–77 (2020).

2.

Polstein, L. R. & Gersbach, C. A. Light-Inducible Spatiotemporal Control of Gene
Activation by Customizable Zinc Finger Transcription Factors. J Am Chem Soc 134,
16480–16483 (2012).

3.

Polstein, L. R. & Gersbach, C. A. A light-inducible CRISPR/Cas9 system for control of
endogenous gene activation. Nat Chem Biol 11, 198–200 (2015).

4.

Shimizu-Sato, S., Huq, E., Tepperman, J. M. & Quail, P. H. A light-switchable gene
promoter system. Nat. Biotechnol. 20, 1041–1044 (2002).

5.

Lu, J. et al. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation
and genome editing. Nucleic Acids Res. 46, e25 (2018).

6.

Gangopadhyay, S. A. et al. Precision Control of CRISPR-Cas9 Using Small Molecules and
Light. Biochemistry 58, 234–244 (2019).

7.

Zhou, X. X. et al. A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for LightInducible Gene Editing and Transcription. ACS Chem. Biol. 13, 443–448 (2018).

8.

Jain, P. K. et al. Development of Light-Activated CRISPR Using Guide RNAs with
Photocleavable Protectors. Angewandte Chemie International Edition 55, 12440–12444
(2016).

9.

Liu, Y. et al. Very fast CRISPR on demand. Science 368, 1265–1269 (2020).

10. Skår, J. et al. Self–organized living systems: conjunction of a stable organization with
chaotic fluctuations in biological space–time. Philosophical Transactions of the Royal

66

Society of London. Series A: Mathematical, Physical and Engineering Sciences 361, 1125–
1139 (2003).
11. Gare, A. Chreods, homeorhesis and biofields: Finding the right path for science through
Daoism. Progress in Biophysics and Molecular Biology 131, 61–91 (2017).
12. Fuente, I. M. D. la et al. On the Dynamics of the Adenylate Energy System: Homeorhesis
vs Homeostasis. PLOS ONE 9, e108676 (2014).
13. Mamontov, E. Modelling homeorhesis by ordinary differential equations. Mathematical
and Computer Modelling 45, 694–707 (2007).
14. Matsushita, Y. & Kaneko, K. Homeorhesis in Waddington’s landscape by epigenetic
feedback regulation. Phys. Rev. Research 2, 023083 (2020).
15. Wiener, N. Cybernetics or Control and Communication in the Animal and the Machine,
Reissue of the 1961 second edition. (MIT Press, 2019).
16. Amen, R. D. A Biological Systems Concept. BioScience 16, 396–401 (1966).
17. Wolkenhauer, O. Systems biology: The reincarnation of systems theory applied in biology?
Brief Bioinform 2, 258–270 (2001).
18. Giuseppin, M. L. F. & van Riel, N. A. W. Metabolic Modeling of Saccharomyces
cerevisiae Using the Optimal Control of Homeostasis: A Cybernetic Model Definition.
Metabolic Engineering 2, 14–33 (2000).
19. Wallach, D. The cybernetics of TNF: Old views and newer ones. Seminars in Cell &
Developmental Biology 50, 105–114 (2016).
20. Hashimshony, T., Feder, M., Levin, M., Hall, B. K. & Yanai, I. Spatiotemporal
transcriptomics reveals the evolutionary history of the endoderm germ layer. Nature 519,
219–222 (2015).

67

21. Morckel, A. R. et al. A photoactivatable small-molecule inhibitor for light-controlled
spatiotemporal regulation of Rho kinase in live embryos. Development 139, 437–442
(2012).
22. Meyer, T. N. et al. Spatiotemporal regulation of morphogenetic molecules during in vitro
branching of the isolated ureteric bud: toward a model of branching through budding in the
developing kidney. Developmental Biology 275, 44–67 (2004).
23. Atwood, C. S. & Vadakkadath Meethal, S. The spatiotemporal hormonal orchestration of
human folliculogenesis, early embryogenesis and blastocyst implantation. Molecular and
Cellular Endocrinology 430, 33–48 (2016).
24. Sandhu, K. S., Li, G., Sung, W.-K. & Ruan, Y. Chromatin interaction networks and higher
order architectures of eukaryotic genomes. Journal of Cellular Biochemistry 112, 2218–
2221 (2011).
25. Kim, M.-S., Kim, J.-R., Kim, D., Lander, A. D. & Cho, K.-H. Spatiotemporal network
motif reveals the biological traits of developmental gene regulatory networks in Drosophila
melanogaster. BMC Syst Biol 6, 31 (2012).
26. Wan, G. et al. Spatiotemporal regulation of liquid-like condensates in epigenetic
inheritance. Nature 557, 679–683 (2018).
27. Zhang, S., Charest, P. G. & Firtel, R. A. Spatiotemporal Regulation of Ras Activity
Provides Directional Sensing. Current Biology 18, 1587–1593 (2008).
28. Gerstenfeld, L. C., Cullinane, D. M., Barnes, G. L., Graves, D. T. & Einhorn, T. A. Fracture
healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of
its regulation. Journal of Cellular Biochemistry 88, 873–884 (2003).
29. Schibler, U. The daily rhythms of genes, cells and organs. EMBO reports 6, S9–S13 (2005).

68

30. Schwartz, W. J. & Meijer, J. H. Real-time imaging reveals spatiotemporal dynamics of
cellular circadian clocks. Trends in Neurosciences 27, 513–516 (2004).
31. Evans, J. A., Leise, T. L., Castanon-Cervantes, O. & Davidson, A. J. Intrinsic Regulation of
Spatiotemporal Organization within the Suprachiasmatic Nucleus. PLOS ONE 6, e15869
(2011).
32. Paganelli, R., Petrarca, C. & Di Gioacchino, M. Biological clocks: their relevance to
immune-allergic diseases. Clinical and Molecular Allergy 16, 1 (2018).
33. Hogenesch, J. B., Panda, S., Kay, S. & Takahashi, J. S. Circadian Transcriptional Output in
the SCN and Liver of the Mouse. in Molecular Clocks and Light Signalling 171–183 (John
Wiley & Sons, Ltd, 2008). doi:10.1002/0470090839.ch13.
34. Balling, R. From mouse genetics to systems biology. Mamm Genome 18, 383–388 (2007).
35. Saez, E., No, D., West, A. & Evans, R. M. Inducible gene expression in mammalian cells
and transgenic mice. Current Opinion in Biotechnology 8, 608–616 (1997).
36. Clackson, T. Controlling mammalian gene expression with small molecules. Current
Opinion in Chemical Biology 1, 210–218 (1997).
37. Fussenegger, M. et al. Streptogramin-based gene regulation systems for mammalian cells.
Nature Biotechnology 18, 1203–1208 (2000).
38. Gupta, S., Schoer, R. A., Egan, J. E., Hannon, G. J. & Mittal, V. Inducible, reversible, and
stable RNA interference in mammalian cells. PNAS 101, 1927–1932 (2004).
39. Kappel, S., Matthess, Y., Kaufmann, M. & Strebhardt, K. Silencing of mammalian genes by
tetracycline-inducible shRNA expression. Nature Protocols 2, 3257–3269 (2007).

69

40. Wu, R.-H. et al. A tightly regulated and reversibly inducible siRNA expression system for
conditional RNAi-mediated gene silencing in mammalian cells. The Journal of Gene
Medicine 9, 620–634 (2007).
41. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by
tetracycline-responsive promoters. PNAS 89, 5547–5551 (1992).
42. No, D., Yao, T. P. & Evans, R. M. Ecdysone-inducible gene expression in mammalian cells
and transgenic mice. PNAS 93, 3346–3351 (1996).
43. Madio, D. P. et al. Invited. On the feasibility of MRI-guided focused ultrasound for local
induction of gene expression. Journal of Magnetic Resonance Imaging 8, 101–104 (1998).
44. Gerner, E. W. et al. Heat-inducible vectors for use in gene therapy. International Journal of
Hyperthermia 16, 171–181 (2000).
45. Yang, W. & Paschen, W. Conditional gene silencing in mammalian cells mediated by a
stress-inducible promoter. Biochemical and Biophysical Research Communications 365,
521–527 (2008).
46. McCarrey, J. R. Evolution of Tissue-Specific Gene Expression in Mammals. BioScience 44,
20–27 (1994).
47. Miyoshi, G. & Fishell, G. Directing neuron-specific transgene expression in the mouse
CNS. Current Opinion in Neurobiology 16, 577–584 (2006).
48. Kos, C. H. Methods in Nutrition Science: Cre/loxP System for Generating Tissue-specific
Knockout Mouse Models. Nutr Rev 62, 243–246 (2004).
49. Gutierrez, A. A., Lemoine, N. R. & Sikora, K. Gene therapy for cancer. The Lancet 339,
715–721 (1992).

70

50. Smith, A. D., Sumazin, P. & Zhang, M. Q. Tissue-specific regulatory elements in
mammalian promoters. Molecular Systems Biology 3, 73 (2007).
51. Tiyaboonchai, A. et al. Utilization of the AAVS1 safe harbor locus for hematopoietic
specific transgene expression and gene knockdown in human ES cells. Stem Cell Research
12, 630–637 (2014).
52. Liu, B. H., Wang, X., Ma, Y. X. & Wang, S. CMV enhancer/human PDGF-β promoter for
neuron-specific transgene expression. Gene Therapy 11, 52–60 (2004).
53. Morton, S. K., Chaston, D. J., Baillie, B. K., Hill, C. E. & Matthaei, K. I. Regulation of
Endothelial-Specific Transgene Expression by the LacI Repressor Protein In Vivo. PLOS
ONE 9, e95980 (2014).
54. Fishman Glenn I. Timing Is Everything in Life. Circulation Research 82, 837–844 (1998).
55. Liu, B., Wang, S., Brenner, M., Paton, J. F. R. & Kasparov, S. Enhancement of cell-specific
transgene expression from a Tet-Off regulatory system using a transcriptional amplification
strategy in the rat brain. The Journal of Gene Medicine 10, 583–592 (2008).
56. Osterwalder, T., Yoon, K. S., White, B. H. & Keshishian, H. A conditional tissue-specific
transgene expression system using inducible GAL4. PNAS 98, 12596–12601 (2001).
57. Bacaj, T. & Shaham, S. Temporal Control of Cell-Specific Transgene Expression in
Caenorhabditis elegans. Genetics 176, 2651–2655 (2007).
58. Sauer, B. Functional expression of the cre-lox site-specific recombination system in the
yeast Saccharomyces cerevisiae. Molecular and Cellular Biology 7, 2087–2096 (1987).
59. Ristevski, S. Making better transgenic models. Mol Biotechnol 29, 153–163 (2005).
60. Ausländer, D. et al. A Synthetic Multifunctional Mammalian pH Sensor and CO2
Transgene-Control Device. Molecular Cell 55, 397–408 (2014).

71

61. Doudna, J. A. & Mali, P. CRISPR-Cas: a laboratory manual. (Cold Spring Harbor
Laboratory Press, 2016).
62. Mali, P. et al. RNA-Guided Human Genome Engineering via Cas9. Science 339, 823–826
(2013).
63. Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR-Cas9-based transcription
factors. Nat Meth 10, 973–976 (2013).
64. Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene
expression. Nature Protocols 8, 2180–2196 (2013).
65. Gilbert, L. A. CRISPR-mediated modular RNA-guided regulation of transcription in
eukaryotes. Cell 154, 442–451 (2013).
66. Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and
transcriptome of living cells. Nature Reviews Genetics 19, 770–788 (2018).
67. Hess, G. T., Tycko, J., Yao, D. & Bassik, M. C. Methods and Applications of CRISPRMediated Base Editing in Eukaryotic Genomes. Molecular Cell 68, 26–43 (2017).
68. Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat.
Methods 12, 326–328 (2015).
69. Makarova, K. S., Wolf, Y. I. & Koonin, E. V. Classification and Nomenclature of CRISPRCas Systems: Where from Here? The CRISPR Journal 1, 325–336 (2018).
70. Makarova, K. S. et al. Evolution and classification of the CRISPR–Cas systems. Nature
Reviews Microbiology 9, 467–477 (2011).
71. Koonin, E. V., Makarova, K. S. & Zhang, F. Diversity, classification and evolution of
CRISPR-Cas systems. Current Opinion in Microbiology 37, 67–78 (2017).

72

72. Zetsche, B. et al. Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas
System. Cell 163, 759–771 (2015).
73. Alok, A. et al. The Rise of the CRISPR/Cpf1 System for Efficient Genome Editing in
Plants. Front. Plant Sci. 11, (2020).
74. Konermann, S. et al. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR
Effectors. Cell 173, 665-676.e14 (2018).
75. Fenno, L., Yizhar, O. & Deisseroth, K. The Development and Application of Optogenetics.
Annual Review of Neuroscience 34, 389–412 (2011).
76. Guru, A., Post, R. J., Ho, Y.-Y. & Warden, M. R. Making Sense of Optogenetics. Int J
Neuropsychopharmacol 18, (2015).
77. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecond-timescale,
genetically targeted optical control of neural activity. Nature Neuroscience 8, 1263–1268
(2005).
78. Pathak, G. P., Vrana, J. D. & Tucker, C. L. Optogenetic control of cell function using
engineered photoreceptors. Biology of the Cell 105, 59–72 (2013).
79. Deisseroth, K. Optogenetics and Psychiatry: Applications, Challenges, and Opportunities.
Biological Psychiatry 71, 1030–1032 (2012).
80. Biselli, T., Lange, S. S., Sablottny, L., Steffen, J. & Walther, A. Optogenetic and
chemogenetic insights into the neurocircuitry of depression-like behaviour: A systematic
review. European Journal of Neuroscience n/a,.
81. Bentley, J. N., Chestek, C., Stacey, W. C. & Patil, P. G. Optogenetics in epilepsy.
Neurosurgical Focus 34, E4 (2013).

73

82. Carter, M. E. & de Lecea, L. Optogenetic investigation of neural circuits in vivo. Trends in
Molecular Medicine 17, 197–206 (2011).
83. Montgomery, K. L., Iyer, S. M., Christensen, A. J., Deisseroth, K. & Delp, S. L. Beyond the
brain: Optogenetic control in the spinal cord and peripheral nervous system. Science
Translational Medicine 8, 337rv5-337rv5 (2016).
84. Grosenick, L., Marshel, J. H. & Deisseroth, K. Closed-Loop and Activity-Guided
Optogenetic Control. Neuron 86, 106–139 (2015).
85. Entcheva, E. Cardiac optogenetics. American Journal of Physiology-Heart and Circulatory
Physiology 304, H1179–H1191 (2013).
86. Johnson, H. E. & Toettcher, J. E. Illuminating developmental biology with cellular
optogenetics. Current Opinion in Biotechnology 52, 42–48 (2018).
87. Pudasaini, A., El-Arab, K. K. & Zoltowski, B. D. LOV-based optogenetic devices: lightdriven modules to impart photoregulated control of cellular signaling. Front. Mol. Biosci. 2,
(2015).
88. Zhang, K. & Cui, B. Optogenetic control of intracellular signaling pathways. Trends in
Biotechnology 33, 92–100 (2015).
89. Rivera-Cancel, G., Motta-Mena, L. B. & Gardner, K. H. Identification of natural and
artificial DNA substrates for the light-activated LOV-HTH transcription factor EL222.
Biochemistry 51, 10024–10034 (2012).
90. Motta-Mena, L. B. et al. An optogenetic gene expression system with rapid activation and
deactivation kinetics. Nature Chemical Biology 10, 196–202 (2014).
91. Reade, A. et al. TAEL: a zebrafish-optimized optogenetic gene expression system with fine
spatial and temporal control. Development 144, 345–355 (2017).

74

92. Ausländer, D. & Fussenegger, M. Optogenetic Therapeutic Cell Implants. Gastroenterology
143, 301–306 (2012).
93. Font Tellado, S., Balmayor, E. R. & Van Griensven, M. Strategies to engineer
tendon/ligament-to-bone interface: Biomaterials, cells and growth factors. Advanced Drug
Delivery Reviews 94, 126–140 (2015).
94. Apostolakos, J. et al. The enthesis: a review of the tendon-to-bone insertion. Muscles
Ligaments Tendons J 4, 333–342 (2014).
95. Lu, H. H. & Thomopoulos, S. Functional attachment of soft tissues to bone: development,
healing, and tissue engineering. Annu Rev Biomed Eng 15, 201–226 (2013).
96. Benjamin, M. & Ralphs, J. R. Entheses--the bony attachments of tendons and ligaments.
Ital J Anat Embryol 106, 151–157 (2001).
97. Min, H. K., Oh, S. H., Lee, J. M., Im, G. I. & Lee, J. H. Porous membrane with reverse
gradients of PDGF-BB and BMP-2 for tendon-to-bone repair: in vitro evaluation on
adipose-derived stem cell differentiation. Acta Biomater 10, 1272–1279 (2014).
98. Hankenson, K. D., Gagne, K. & Shaughnessy, M. Extracellular signaling molecules to
promote fracture healing and bone regeneration. Adv. Drug Deliv. Rev. 94, 3–12 (2015).
99. Hee, C. K., Dines, J. S., Solchaga, L. A., Shah, V. R. & Hollinger, J. O. Regenerative
tendon and ligament healing: opportunities with recombinant human platelet-derived
growth factor BB-homodimer. Tissue Eng Part B Rev 18, 225–234 (2012).
100. Zhang, Y., Cheng, N., Miron, R., Shi, B. & Cheng, X. Delivery of PDGF-B and BMP-7 by
mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects.
Biomaterials 33, 6698–6708 (2012).

75

101. Babensee, J. E., McIntire, L. V. & Mikos, A. G. Growth Factor Delivery for Tissue
Engineering. Pharm Res 17, 497–504 (2000).
102. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339,
819–823 (2013).
103. Jinek, M. et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive
Bacterial Immunity. Science 337, 816–821 (2012).
104. Alford, S. C., Wu, J., Zhao, Y., Campbell, R. E. & Knöpfel, T. Optogenetic reporters.
Biology of the Cell 105, 14–29 (2013).
105. Gao, Y. & Zhao, Y. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro
and in vivo for CRISPR-mediated genome editing. Journal of Integrative Plant Biology 56,
343–349 (2014).
106. Sakata, R. C. et al. Base editors for simultaneous introduction of C-to-T and A-to-G
mutations. Nat. Biotechnol. 38, 865–869 (2020).
107. Grünewald, J. et al. CRISPR DNA base editors with reduced RNA off-target and selfediting activities. Nat. Biotechnol. 37, 1041–1048 (2019).
108. Covacu, R., Perez Estrada, C., Arvidsson, L., Svensson, M. & Brundin, L. Change of fate
commitment in adult neural progenitor cells subjected to chronic inflammation. J. Neurosci.
34, 11571–11582 (2014).
109. Johansson, C. B. et al. Identification of a neural stem cell in the adult mammalian central
nervous system. Cell 96, 25–34 (1999).
110. Garg, K. & Bowlin, G. L. Electrospinning jets and nanofibrous structures. Biomicrofluidics
5, 013403 (2011).

76

111. Sell, S. A., McClure, M. J., Ayres, C. E., Simpson, D. G. & Bowlin, G. L. Preliminary
Investigation of Airgap Electrospun Silk-Fibroin-Based Structures for Ligament Analogue
Engineering. Journal of Biomaterials Science, Polymer Edition 22, 1253–1273 (2011).
112. Jha, B. S. et al. Two pole air gap electrospinning: Fabrication of highly aligned, threedimensional scaffolds for nerve reconstruction. Acta Biomaterialia 7, 203–215 (2011).
113. Zhao, L., Thambyah, A. & Broom, N. D. A multi-scale structural study of the porcine
anterior cruciate ligament tibial enthesis. Journal of Anatomy 224, 624–633 (2014).
114. Pal, S. Design of Artificial Human Joints & Organs. (Springer US, 2014). doi:10.1007/9781-4614-6255-2.
115. Butler, D. L. et al. Location-dependent variations in the material properties of the anterior
cruciate ligament. J Biomech 25, 511–518 (1992).
116. Dimitriou, R. et al. Application of recombinant BMP-7 on persistent upper and lower limb
non-unions. Injury 36, S51–S59 (2005).
117. Haidar, Z. S., Hamdy, R. C. & Tabrizian, M. Delivery of recombinant bone morphogenetic
proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery.
Biotechnol Lett 31, 1817 (2009).
118. Epstein, N. E. Complications due to the use of BMP/INFUSE in spine surgery: The
evidence continues to mount. Surg Neurol Int 4, S343–S352 (2013).
119. Borges, A. L., Davidson, A. R. & Bondy-Denomy, J. The Discovery, Mechanisms, and
Evolutionary Impact of Anti-CRISPRs. Annu Rev Virol 4, 37–59 (2017).
120. Stanley, S. Y. & Maxwell, K. L. Phage-Encoded Anti-CRISPR Defenses. Annu. Rev.
Genet. 52, 445–464 (2018).

77

121. Marino, N. D., Pinilla-Redondo, R., Csörgő, B. & Bondy-Denomy, J. Anti-CRISPR protein
applications: natural brakes for CRISPR-Cas technologies. Nature Methods 17, 471–479
(2020).
122. Maini, A. K. Digital Electronics: Principles, Devices and Applications. (Wiley, 2007).

78

